US5414049A - Non-oxidizing polymeric medical implant - Google Patents

Non-oxidizing polymeric medical implant Download PDF

Info

Publication number
US5414049A
US5414049A US08/070,074 US7007493A US5414049A US 5414049 A US5414049 A US 5414049A US 7007493 A US7007493 A US 7007493A US 5414049 A US5414049 A US 5414049A
Authority
US
United States
Prior art keywords
implant
producing
set forth
oxygen
atmosphere
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
US08/070,074
Inventor
Deh-Chuan Sun
Casper F. Stark
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Howmedica Osteonics Corp
Original Assignee
Howmedica Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22092961&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=US5414049(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Howmedica Inc filed Critical Howmedica Inc
Priority to US08/070,074 priority Critical patent/US5414049A/en
Assigned to HOWMEDICA, INC. reassignment HOWMEDICA, INC. ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: STARK, CASPER F., SUN, DEH-CHUAN
Priority to AT00200859T priority patent/ATE302032T1/en
Priority to EP98103006A priority patent/EP0847765B1/en
Priority to AU64364/94A priority patent/AU684500B2/en
Priority to JP7500438A priority patent/JP2836965B2/en
Priority to EP00200859A priority patent/EP1005872B1/en
Priority to PCT/IB1994/000083 priority patent/WO1994027651A1/en
Priority to EP05017610A priority patent/EP1598086A2/en
Priority to DE69413395T priority patent/DE69413395T2/en
Priority to AT94912052T priority patent/ATE171078T1/en
Priority to DE9490446U priority patent/DE9490446U1/en
Priority to DE69425838T priority patent/DE69425838T2/en
Priority to DE69434462T priority patent/DE69434462T2/en
Priority to ES94912052T priority patent/ES2122260T3/en
Priority to AT98103006T priority patent/ATE196095T1/en
Priority to EP94912052A priority patent/EP0701453B1/en
Priority to CA002162927A priority patent/CA2162927C/en
Priority to US08/320,705 priority patent/US5449745A/en
Priority to US08/404,663 priority patent/US5543471A/en
Application granted granted Critical
Publication of US5414049A publication Critical patent/US5414049A/en
Priority to US08/439,028 priority patent/US5650485A/en
Priority to US08/733,067 priority patent/US5728748A/en
Priority to US09/012,345 priority patent/US6174934B1/en
Assigned to STRYKER TECHNOLOGIES CORPORATION reassignment STRYKER TECHNOLOGIES CORPORATION ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: HOWMEDICA INC.
Assigned to BANK OF AMERICA NATIONAL TRUST AND SAVINGS ASSOCIATION reassignment BANK OF AMERICA NATIONAL TRUST AND SAVINGS ASSOCIATION SECURITY AGREEMENT Assignors: STRYKER CORPORATION, STRYKER FAR EAST, INC.
Assigned to BANK OF AMERICA NATIONAL TRUST AND SAVINGS ASSOCIATION reassignment BANK OF AMERICA NATIONAL TRUST AND SAVINGS ASSOCIATION SECURITY INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: HOWMEDICA CORPORATION, HOWMEDICA LEIBINGER, INC., SMD CORPORATION, STRYKER CORPORATION, STRYKER FAR EAST, INC., STRYKER FOREIGN HOLDCO INC., STRYKER IMPLANTS INC., STRYKER INTERNATIONAL INC., STRYKER PUERTO RICO INC., STRYKER SALES CORPORATION, STRYKER TECHNOLOGIES CORPORATION
Priority to US09/604,868 priority patent/US6372814B1/en
Priority to US10/041,118 priority patent/US6664308B2/en
Assigned to HOWMEDICA OSTEONICS CORPORATION, STRYKER PUERTO RICO INC., STRYKER TECHNOLOGIES CORPORATION, STRYKER INTERNATIONAL, INC., STRYKER CORPORATION, HOWMEDICAL LEIBINGER, INC., SMD CORPORATION, STRYKER FAR EAST, INC., PHYSIOTHERAPY ASSOCIATES, INC., STRYKER SALES CORPORATION, STRYKER FOREIGN HOLDCO, INC. reassignment HOWMEDICA OSTEONICS CORPORATION RELEASE OF SECURITY INTEREST Assignors: BANK OF AMERICA, N.A. (F/K/A BANK OF AMERICA NATIONAL TRUST AND SAVINGS ASSOCIATION)
Priority to US10/461,636 priority patent/US6818020B2/en
Assigned to HOWMEDICA OSTEONICS CORP. reassignment HOWMEDICA OSTEONICS CORP. ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: STRYKER TECHNOLOGIES CORPORATION
Priority to US10/935,510 priority patent/US20050059750A1/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
    • A61L2/02Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor using physical phenomena
    • A61L2/08Radiation
    • A61L2/081Gamma radiation
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/42Use of materials characterised by their function or physical properties
    • A61L15/60Liquid-swellable gel-forming materials, e.g. super-absorbents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
    • A61L2/02Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor using physical phenomena
    • A61L2/08Radiation
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
    • A61L2/02Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor using physical phenomena
    • A61L2/08Radiation
    • A61L2/082X-rays
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
    • A61L2/02Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor using physical phenomena
    • A61L2/08Radiation
    • A61L2/087Particle radiation, e.g. electron-beam, alpha or beta radiation
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14Macromolecular materials
    • A61L27/16Macromolecular materials obtained by reactions only involving carbon-to-carbon unsaturated bonds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L29/00Materials for catheters, medical tubing, cannulae, or endoscopes or for coating catheters
    • A61L29/04Macromolecular materials
    • A61L29/041Macromolecular materials obtained by reactions only involving carbon-to-carbon unsaturated bonds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/04Macromolecular materials
    • A61L31/048Macromolecular materials obtained by reactions only involving carbon-to-carbon unsaturated bonds
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B29WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
    • B29CSHAPING OR JOINING OF PLASTICS; SHAPING OF MATERIAL IN A PLASTIC STATE, NOT OTHERWISE PROVIDED FOR; AFTER-TREATMENT OF THE SHAPED PRODUCTS, e.g. REPAIRING
    • B29C35/00Heating, cooling or curing, e.g. crosslinking or vulcanising; Apparatus therefor
    • B29C35/02Heating or curing, e.g. crosslinking or vulcanizing during moulding, e.g. in a mould
    • B29C35/08Heating or curing, e.g. crosslinking or vulcanizing during moulding, e.g. in a mould by wave energy or particle radiation
    • B29C35/0805Heating or curing, e.g. crosslinking or vulcanizing during moulding, e.g. in a mould by wave energy or particle radiation using electromagnetic radiation
    • B29C2035/085Heating or curing, e.g. crosslinking or vulcanizing during moulding, e.g. in a mould by wave energy or particle radiation using electromagnetic radiation using gamma-ray
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B29WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
    • B29CSHAPING OR JOINING OF PLASTICS; SHAPING OF MATERIAL IN A PLASTIC STATE, NOT OTHERWISE PROVIDED FOR; AFTER-TREATMENT OF THE SHAPED PRODUCTS, e.g. REPAIRING
    • B29C35/00Heating, cooling or curing, e.g. crosslinking or vulcanising; Apparatus therefor
    • B29C35/02Heating or curing, e.g. crosslinking or vulcanizing during moulding, e.g. in a mould
    • B29C35/08Heating or curing, e.g. crosslinking or vulcanizing during moulding, e.g. in a mould by wave energy or particle radiation
    • B29C35/0805Heating or curing, e.g. crosslinking or vulcanizing during moulding, e.g. in a mould by wave energy or particle radiation using electromagnetic radiation
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B29WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
    • B29CSHAPING OR JOINING OF PLASTICS; SHAPING OF MATERIAL IN A PLASTIC STATE, NOT OTHERWISE PROVIDED FOR; AFTER-TREATMENT OF THE SHAPED PRODUCTS, e.g. REPAIRING
    • B29C43/00Compression moulding, i.e. applying external pressure to flow the moulding material; Apparatus therefor
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B29WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
    • B29CSHAPING OR JOINING OF PLASTICS; SHAPING OF MATERIAL IN A PLASTIC STATE, NOT OTHERWISE PROVIDED FOR; AFTER-TREATMENT OF THE SHAPED PRODUCTS, e.g. REPAIRING
    • B29C43/00Compression moulding, i.e. applying external pressure to flow the moulding material; Apparatus therefor
    • B29C43/02Compression moulding, i.e. applying external pressure to flow the moulding material; Apparatus therefor of articles of definite length, i.e. discrete articles
    • B29C43/16Forging
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B29WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
    • B29KINDEXING SCHEME ASSOCIATED WITH SUBCLASSES B29B, B29C OR B29D, RELATING TO MOULDING MATERIALS OR TO MATERIALS FOR MOULDS, REINFORCEMENTS, FILLERS OR PREFORMED PARTS, e.g. INSERTS
    • B29K2023/00Use of polyalkenes or derivatives thereof as moulding material
    • B29K2023/04Polymers of ethylene
    • B29K2023/06PE, i.e. polyethylene
    • B29K2023/0658PE, i.e. polyethylene characterised by its molecular weight
    • B29K2023/0683UHMWPE, i.e. ultra high molecular weight polyethylene
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B29WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
    • B29KINDEXING SCHEME ASSOCIATED WITH SUBCLASSES B29B, B29C OR B29D, RELATING TO MOULDING MATERIALS OR TO MATERIALS FOR MOULDS, REINFORCEMENTS, FILLERS OR PREFORMED PARTS, e.g. INSERTS
    • B29K2105/00Condition, form or state of moulded material or of the material to be shaped
    • B29K2105/25Solid
    • B29K2105/253Preform
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B29WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
    • B29KINDEXING SCHEME ASSOCIATED WITH SUBCLASSES B29B, B29C OR B29D, RELATING TO MOULDING MATERIALS OR TO MATERIALS FOR MOULDS, REINFORCEMENTS, FILLERS OR PREFORMED PARTS, e.g. INSERTS
    • B29K2995/00Properties of moulding materials, reinforcements, fillers, preformed parts or moulds
    • B29K2995/0037Other properties
    • B29K2995/0087Wear resistance
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B29WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
    • B29KINDEXING SCHEME ASSOCIATED WITH SUBCLASSES B29B, B29C OR B29D, RELATING TO MOULDING MATERIALS OR TO MATERIALS FOR MOULDS, REINFORCEMENTS, FILLERS OR PREFORMED PARTS, e.g. INSERTS
    • B29K2995/00Properties of moulding materials, reinforcements, fillers, preformed parts or moulds
    • B29K2995/0037Other properties
    • B29K2995/0089Impact strength or toughness
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B29WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
    • B29LINDEXING SCHEME ASSOCIATED WITH SUBCLASS B29C, RELATING TO PARTICULAR ARTICLES
    • B29L2031/00Other particular articles
    • B29L2031/753Medical equipment; Accessories therefor
    • B29L2031/7532Artificial members, protheses
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S522/00Synthetic resins or natural rubbers -- part of the class 520 series
    • Y10S522/915Synthetic resins or natural rubbers -- part of the class 520 series involving inert gas, steam, nitrogen gas, or carbon dioxide
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S525/00Synthetic resins or natural rubbers -- part of the class 520 series
    • Y10S525/937Utility as body contact e.g. implant, contact lens or I.U.D.
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S623/00Prosthesis, i.e. artificial body members, parts thereof, or aids and accessories therefor
    • Y10S623/901Method of manufacturing prosthetic device

Definitions

  • This invention relates to medical implants formed of a polymeric material such as ultra-high molecular weight polyethylene, with superior oxidation resistance upon irradiation and a method for making the same.
  • Ultra-high molecular weight polyethylene is widely used for articulation surfaces in artificial knee and hip replacements.
  • Ultra-high molecular weight polyethylene (UHMWPE) has been defined as those linear polyethylenes which have a relative viscosity of 2.3 or greater at a solution concentration of 0.05% at 135° C. in decahydronaphthalene.
  • the nominal weight--average molecular weight is at least 400,000 and up to 10,000,000 and usually from three to six million.
  • the manufacturing process begins with the polymer being supplied as fine powder which is consolidated into various forms, such as rods and slabs, using ram extrusion or compression molding. Afterwards, the consolidated rods or slabs are machined into the final shape of the orthopedic implant components. Alternatively, the component can be produced by compression molding of the UHMWPE resin powder.
  • gamma ray, x-ray or electron beam radiation has been utilized as a preferred means of sterilization. These types of radiation use a high energy beam to kill bacteria, viruses, or other microbial species contained in the packaged medical products, achieving the goal of product sterility.
  • reaction 7 the hydroperoxides (rOOH and POOH) formed in reactions 3 and 5 will slowly break down as shown in reaction 7 to initiate post-radiation degradation.
  • Reactions 8 and 9 represent termination steps of free radicals to form ester or carbon-carbon cross-links.
  • the extent of reaction 8 and 9 in relation to reactions 2 through 7 may vary.
  • irradiated UHMWPE a value of 0.3 for the ratio of chain scission to cross-linking has been obtained, indicating that even though cross-linking is a dominant mechanism, a significant amount of chain scission occurs in irradiated polyethylene.
  • the primary free radicals r. or secondary free radicals P. can only react with other neighboring free radicals to form carbon-carbon cross-links, according to reactions 10 through 12 below. If all the free radicals react through reactions 10 through 12, there will be no chain scission and there will be no molecular weight degradation. Furthermore, the extent of cross-linking is increased over the original polymer prior to irradiation. On the other hand, if not all the free radicals formed are combined through reactions 10, 11 and 12, then some free radicals will remain in the plastic component. ##STR3##
  • UHMWPE powders being heated and compressed into a homogeneously melted crystallized morphology with no grain memory of the UHMWPE powder particles and with enhanced modulus and strength.
  • U.S. Pat. No. 5,037,928 discloses a prescribed heating and cooling process for preparing a UHMWPE exhibiting a combination of properties including a creep resistance of less than 1% (under exposure to a temperature of 23° C. and a relative humidity of 50% for 24 hours under a compression of 1000 psi) without sacrificing tensile and flexural properties.
  • Patent Application GB 2 180 815 A discloses a packaging method where a medical device which is sealed in a sterile bag, after radiation/sterilization, is hermetically sealed in a wrapping member of oxygen-impermeable material together with a deoxidizing agent for prevention of post-irradiation oxidation.
  • U.S. Pat. No. 5,153,039 relates to a high density polyethylene article with oxygen barrier properties.
  • U.S. Pat. No. 5,160,464 relates to a vacuum polymer irradiation process.
  • the present invention relates to a method for providing a polymeric material, such as UHMWPE, with superior oxidation resistance upon irradiation.
  • a polymeric material such as UHMWPE
  • UHMWPE will be used as an example to describe the invention.
  • all the theories and processes described hereafter should also apply to other polymeric materials such as polypropylene, high density polyethylene, polyester, nylon, polyurethane and poly(methylmethacrylate) unless otherwise stated.
  • UHMWPE polymer is very stable and has very good resistance to aggressive media except for strong oxidizing acids.
  • free radicals are formed which cause UHMWPE to become activated for chemical reactions and physical changes.
  • Possible chemical reactions include reacting with oxygen, water, body fluids, and other chemical compounds while physical changes include density, crystallinity, color, and other physical properties.
  • a new sterilization radiation process greatly reduces the adverse effects caused by a conventional radiation process.
  • this new sterilization process does not employ stabilizers, antioxidants, or any other chemical compounds which may have potential adverse effects in biomedical or orthopedic applications.
  • a polymeric orthopedic implant component to be sterilized by radiation does not contain oxidants, such as oxygen or water (or moisture), or free radicals. This may be accomplished by obtaining a raw material for the implant manufactured under a special process as described herein and forming a part of the invention.
  • the finished polymeric orthopedic component is then sealed in an oxidant-free atmosphere.
  • This oxidant-free atmosphere is maintained during radiation.
  • the radiated polymeric component is then subjected to a heat treatment to cross-link all the free radicals within themselves. During this treatment, the condition of oxidant-free atmosphere is maintained.
  • the irradiated, heat treated plastic component is now ready to use. Exposure to oxygen or moisture will not cause oxidation.
  • the oxidation resistance to any oxidizing agent is similar to that of the unirradiated virgin polymer.
  • a method for producing a polymeric medical implant including the steps of placing the polymeric resin in a sealed container and removing a substantial portion of the oxygen from the container. After a predetermined time, the container is repressurized with an inert gas such as nitrogen, argon, helium or neon. The resin is thereafter transferred to a forming device which normally melts and forms the resin in an oxygen reduced atmosphere to produce a polymeric raw material.
  • the polymeric raw material such as UHMWPE is then machined to an implant such as a tibial tray or a liner for an acetabular cup. The finished part is then sealed into a package in an oxygen reduced atmosphere.
  • the package is of an air-tight nature to prevent oxygen or moisture from entering after the package is sealed.
  • the then packaged implant is radiation sterilized and then heat treated for the predetermined time and temperature sufficient to form cross-links between free radicals of the neighboring polymeric chains. This prevents further oxidation once the implant is removed from the package.
  • the implant is heated for at least 48 hours at a temperature of about 37° C. to about 70° C. and preferably for 144 hours at 50° C.
  • a raw polymeric material such as UHMWPE is obtained by, for example, ram extrusion, compression molding, or other forming processes.
  • virgin polymer resin powder may contain air or moisture, which may exist in the resin micro-structure or simply deposited on the resin surfaces. If air or moisture is not removed from resin powder prior to the forming process, it can be trapped in the plastic matrix after forming and can not escape. This is true even with the use of vacuum or gas flushing techniques.
  • the trapped air or moisture or both will react with free radicals generated in the plastic to cause oxidation.
  • the trapped moisture can also absorb radiation energy and dissociate into oxygen and hydroxyl free radicals which will also react with the plastic to cause oxidation. Therefore, by removing air and moisture prior to the forming process, oxidation during sterilization radiation can be avoided.
  • the preferred method for eliminating air and moisture is to apply a vacuum of less than 3" of mercury (76 torr) to the polymer resin for a prescribed time to reduce the levels of air and moisture to a minimal or acceptable value.
  • the level for oxygen is preferably 0.5% (volume by volume and no more than 1%).
  • the moisture level is preferably 10% of relative humidity (and no more than 20% relative humidity).
  • sufficient amounts of deoxidizing agents, such as oxygen absorbents and moisture desiccants are placed together with the polymer resin in a sealed container to reduce the levels of air and moisture to the minimal or acceptable value.
  • An example of an oxygen absorbent is AGELESS® which is an iron oxide compound and commercially available from Cryovac Division, W. R. Grace & Co., Duncan, S.C.
  • moisture desiccant is silica gel which is commercially available. These materials are placed with the resin in the sealed container for approximately 10 hours. Alternately, or in combination, an inert gas, such as nitrogen, argon, helium or neon is used to flush the container, holding the polymer resin powder, until the levels of air and moisture are reduced to the accepted value. Of course, any combination of the above methods can also be used.
  • an inert gas such as nitrogen, argon, helium or neon is used to flush the container, holding the polymer resin powder, until the levels of air and moisture are reduced to the accepted value.
  • nitrogen, argon, helium or neon is used to flush the container, holding the polymer resin powder, until the levels of air and moisture are reduced to the accepted value.
  • any combination of the above methods can also be used.
  • the entire forming operation of, for example, ram extrusion, compression molding, or other forming process should be carried out in an inert or low oxygen atmosphere as well.
  • UHMWPE polymer chains may be broken to generate free radicals and cross-links. While cross-links generated in the forming process have no adverse effects on material properties, the free radicals produced, as described above, can react with air or other oxidants. Therefore, it is important to maintain the inert atmosphere during the forming process to minimize oxidation.
  • any free radicals generated should be eliminated as soon as the forming process is completed by annealing. If the formed UHMWPE contains free radicals and is exposed to air or other oxidants after the forming process, oxidation will occur.
  • the polymer should be annealed at an elevated temperature in an inert atmosphere for a prescribed time. This is because the rate of free radical reactions (reactions 10 through 12) increase with increasing temperature, according to the following general expressions: ##EQU1##
  • an elevated temperature Compared to room temperature, an elevated temperature not only increases the reaction rate constants, k 1 , and k 2 , but also helps free radicals r. and P. to migrate in the plastic matrix to meet other neighboring free radicals for cross-linking reactions.
  • the desired elevated temperature is between the room temperature and the melting point of the polymer.
  • this temperature range is between about 25° C. and about 140° C.
  • the preferred annealing temperature range is from about 37° C. to about 135° C.
  • the preferred time and temperature is 130° C. for 20 hours with the minimum annealing time being about 4 hours (requiring a temperature at the high end of the range). It is to be noted that the higher the temperature used, the shorter the time period needed to combine free radicals.
  • the formed UHMWPE often contains residual (internal) stress caused by incomplete relaxation during the cooling process, which is the last step of the forming process.
  • the annealing process described herein will also help to eliminate or reduce the residual stress.
  • a residual stress contained in a plastic matrix can cause dimensional instability and is in general undesirable.
  • the formed UHMWPE is further machined into desired shapes.
  • the machining is done at room temperature and no damage to the plastic will occur.
  • certain machine tools when operated at a high speed, may generate local heat and cause thermal breakdown of UHMWPE polymer chains.
  • the above described annealing process may be employed to eliminate any newly formed free radicals prior to packaging.
  • the polymeric component After machining, the polymeric component is packaged in an air tight package in an oxidant-free atmosphere. Thus, all air and moisture must be removed from the package prior to the sealing step. Machines to accomplish this are commercially available, such as from Orics Industries Inc., College Point, N.Y. which flush the package with a chosen inert gas, vacuum the container, flush the container for the second time, and then heat seal the container with a lid. In general, less than 0.5% (volume by volume) oxygen concentration can be obtained consistently.
  • An example of a suitable oxidant impermeable (air tight) packaging material is polyethylene terephthalate (PET).
  • PET poly(ethylene vinyl alcohol) and aluminum foil, whose oxygen and water vapor transmission rates are essentially zero.
  • Suitable commercial packaging materials utilize a layer structure to form a composite material with superior oxygen and moisture barrier properties.
  • An example of this type is a layered composite comprised of poly-propylene/poly(ethylene vinyl alcohol)/polypropylene.
  • the sterilization radiation step for the packaged implant may take a few hours to complete. As described above, it is imperative that during this time period, the transmission of oxidants, such as oxygen and moisture, into the package be kept to a minimal or at an acceptable value to avoid oxidation.
  • a heat treatment step should be performed in an inert atmosphere and at an elevated temperature to cause free radicals to form cross-links without oxidation. If proper packaging materials and processes are used and oxidant transmission rates are minimal, then the oxidant-free atmosphere can be maintained in the package and a regular oven with air circulation can be used for heat treatment after sterilization. To absolutely ensure that no oxidants leak into the package, the oven may be operated under a vacuum or purged with an inert gas. In general, if a higher temperature is used, a shorter time period is required to achieve a prescribed level of oxidation resistance and cross-linking. In many cases, the relationship between the reaction temperature and the reaction rate follows the well-known Arrhennius equation:
  • the temperature should not exceed the distortion temperature of either the packaging material or the plastic components.
  • the temperature range is between about 25° C. and about 140° C.
  • the preferred temperature is 37° C. to 70° C.
  • a surgical grade UHMWPE rod produced by ram extrusion was machined into samples of desirable shapes. Four sets of samples were prepared using these machined samples by the following methods:
  • Method A an UHMWPE sample as machined and unirradiated
  • Method B An UHMWPE sample was heat sealed in a glycol-modified polyethylene terephthalate (PETG, made by Eastman Plastics, Inc., Kingsport, Tenn.) blister in air with an aluminum lid of 0.1 mm in thickness.
  • PETG polyethylene terephthalate
  • the sealed blister containing the UHMWPE sheet was sterilized by irradiation of gamma-rays in a dose of 2.5 Mrad. The package was then opened and exposed to room air.
  • Method C An UHMWPE sample was placed in a PETG blister and heat sealed in dry nitrogen with an aluminum lid of 0.1 mm in thickness by the Orics Vacuum Gas Flush Heat Seal Machine (Model SLS-VGF-100M for modified atmosphere packaging, made by Orics Industries Inc., College Point, N.Y.) which went through the following cycles: i) nitrogen gas (moisture-free) flush for five seconds ii) vacuum to a pressure of equal to or below 3 inches of mercury iii) nitrogen gas flush (moisture-free) for five seconds iv) heat seal
  • the oxygen concentration in the sealed blister was measured by a Mocon Oxygen Analyzer to be 0.325% (volume by volume).
  • the sealed blister containing the UHMWPE sample was sterilized by irradiation of gamma-rays in a dose of 2.5 Mrad.
  • the oxygen concentration in the sealed blister after sterilization radiation was measured to be 0.350%.
  • the package was then opened and exposed to room air.
  • the sealed blister containing the UHMWPE sample was heat treated at 50° C. for 144 hours in an oven, then transferred from the oven to room temperature for cooling. After the package was cooled to room temperature, the oxygen concentration was measured by a Mocon Oxygen Analyzer to be 0.360%. The package was then opened and exposed to room air.
  • the peak area is proportional to the amount of oxidized UHMWPE in the specimen.
  • the integrated peak area was then normalized to the specimen thickness, by dividing by the area of the 1463 cm -1 (methyl) peak which is proportional to the specimen thickness. The obtained ratio was defined as oxidation index.
  • tensile breaking strength shows the most deterioration for the sample irradiated in air (Method B).
  • the sample irradiated in nitrogen (Method C) shows some improvement over the sample prepared by Method B.
  • the decrease in tensile breaking strength upon oven aging still occurs.
  • the sample irradiated in nitrogen followed by heat treatment shows no change in tensile breaking strength, indicating a superior oxidation resistance.
  • the column Prior to sample runs, the column was calibrated using narrow MW polystyrene standards. Since the samples were only partially soluble in the solvent due to cross-linking, the so-determined molecular weight distribution was for the soluble portion only.
  • the filters were cooled to room temperature and washed individually with dichloromethane. They were then placed in a convection oven at 105° C. for 6 hours to dry and then reweighed. The weight fraction of the undissolved (cross-linked) portion was then determined based upon the initial weight of 200 mg. To determine the low molecular weight fraction present in each sample, the weight fraction of molecular weight below 10 5 in the soluble portion, determined by GPC, was multiplied by the percent solubility to give weight percent of low molecular weight fraction in each sample. Results are shown in Table 3:
  • the sample made by Method D contains more cross-linking (i.e. less soluble) than one made by Method B.
  • the low molecular weight fraction (defined as below 10 5 ) in the sample made by Method B increases from 0.275 to 0.481 while that of the sample made by Method D remains virtually unchanged at about 0.18 after 23 days of oven aging.
  • the increase in low molecular weight fraction was due to chain scission caused by oxidative reactions.
  • the results indicate that the process of method D can produce an irradiated polymer with a superior oxidation resistance.
  • the sample annealed in nitrogen exhibits a higher elongation at break, a higher tensile breaking strength, and a higher toughness, compared to one annealed in air, while the tensile yield strength is similar between the two samples.
  • the results indicate that the sample annealed in nitrogen is more ductile than the one annealed in air.
  • the loss of ductility in the sample annealed in air is due to oxidative chain scission.
  • Oxidation indices in these two samples a thin film specimen of ca. 100 microns in thickness was cut from each of the 1-mm-thick annealed UHMWPE sheets and placed in an IR window for a standard FTIR (a Nicolet 710 FTIR system was used) transmission run, using the procedures and calculations employed in the Sample Preparation. Oxidation indices obtained are shown in Table 6.

Abstract

A medical implant made of polymeric material having an increased oxidation resistance is formed by a method including the steps of placing a resin powder in a sealed container. A substantial portion of the oxygen is removed from the sealed container by either a vacuum, an oxygen absorbent or by flushing with inert gas. The container is then repressurized with a gas such as nitrogen, argon, helium or neon so that long term storage may be possible. On use, the resin is transferred to a forming device which both melts and forms the resin in an oxygen reduced atmosphere to produce a polymeric raw material such as a rod or bar stock. The medical implant is then formed from this raw material annealed and sealed in an airtight package in an oxygen reduced atmosphere. The implant is then radiation sterilized and thereafter annealed in the package for a predetermined time and temperature sufficient to form cross-links between any free radicals in neighboring polymeric chains.

Description

BACKGROUND OF THE INVENTION
2. Field of the Invention
This invention relates to medical implants formed of a polymeric material such as ultra-high molecular weight polyethylene, with superior oxidation resistance upon irradiation and a method for making the same.
2. Description of the Prior Art
Various polymer systems have been used for the preparation of artificial prostheses for biomedical use, particularly orthopedic applications. Among them, ultra-high molecular weight polyethylene is widely used for articulation surfaces in artificial knee and hip replacements. Ultra-high molecular weight polyethylene (UHMWPE) has been defined as those linear polyethylenes which have a relative viscosity of 2.3 or greater at a solution concentration of 0.05% at 135° C. in decahydronaphthalene. The nominal weight--average molecular weight is at least 400,000 and up to 10,000,000 and usually from three to six million. The manufacturing process begins with the polymer being supplied as fine powder which is consolidated into various forms, such as rods and slabs, using ram extrusion or compression molding. Afterwards, the consolidated rods or slabs are machined into the final shape of the orthopedic implant components. Alternatively, the component can be produced by compression molding of the UHMWPE resin powder.
All components must then go through a sterilization procedure prior to use, but usually after being packaged. There exists several sterilization methods which can be utilized for medical applications, such as the use of ethylene oxide, heat, or radiation. However, applying heat to a packaged polymeric medical product can destroy either the integrity of the packaging material (particularly the seal, which prevents bacteria from going into the package after the sterilization step) or the product itself.
Because ethylene oxide may adversely impact environmental and employee safety, gamma ray, x-ray or electron beam radiation has been utilized as a preferred means of sterilization. These types of radiation use a high energy beam to kill bacteria, viruses, or other microbial species contained in the packaged medical products, achieving the goal of product sterility.
However, it has been recognized that regardless of the radiation type, the high energy beam causes generation of free radicals in polymers during radiation. It has also been recognized that the amount of free radicals generated is dependent upon the radiation dose received by the polymers and that the distribution of free radicals in the polymeric implant depends upon the geometry of the component, the type of polymer, the dose rate, and the type of radiation beam. The generation of free radicals can be described by the following reaction (which uses polyolefin and gamma ray irradiation for illustration): ##STR1## Depending whether or not oxygen is present, primary free radicals r. will react with oxygen and the polymer according to the following reactions as described in "Radiation Effects on Polymers", edited by Roger L. Clough and Shalaby W. Shalaby, published by American Chemical Society, Washington, D.C., 1991. ##STR2##
In radiation in air, primary free radicals r. will react with oxygen to form peroxyl free radicals rO2., which then react with polyolefin (such as UHMWPE) to start the oxidative chain scission reactions (reactions 2 through 6). Through these reactions, material properties of the plastic, such as molecular weight, tensile, and wear properties, are degraded.
Recently, it was found that the hydroperoxides (rOOH and POOH) formed in reactions 3 and 5 will slowly break down as shown in reaction 7 to initiate post-radiation degradation. Reactions 8 and 9 represent termination steps of free radicals to form ester or carbon-carbon cross-links. Depending on the type of polymer, the extent of reaction 8 and 9 in relation to reactions 2 through 7 may vary. For irradiated UHMWPE, a value of 0.3 for the ratio of chain scission to cross-linking has been obtained, indicating that even though cross-linking is a dominant mechanism, a significant amount of chain scission occurs in irradiated polyethylene.
By applying radiation in an inert atmosphere, since there is no oxidant present, the primary free radicals r. or secondary free radicals P. can only react with other neighboring free radicals to form carbon-carbon cross-links, according to reactions 10 through 12 below. If all the free radicals react through reactions 10 through 12, there will be no chain scission and there will be no molecular weight degradation. Furthermore, the extent of cross-linking is increased over the original polymer prior to irradiation. On the other hand, if not all the free radicals formed are combined through reactions 10, 11 and 12, then some free radicals will remain in the plastic component. ##STR3##
It is recognized that the fewer the free radicals, the better the polymer retains its physical properties over time. The greater the number of free radicals, the greater the degree of molecular weight and polymer property degradation will occur. Applicant has discovered that the extent of completion of free radical cross-linking reactions is dependent on the reaction rates and the time period given for reaction to occur.
Several prior art patents attempt to provide methods which enhance UHMWPE physical properties. European Patent Application 0 177 522 B1 discloses UHMWPE powders being heated and compressed into a homogeneously melted crystallized morphology with no grain memory of the UHMWPE powder particles and with enhanced modulus and strength. U.S. Pat. No. 5,037,928 discloses a prescribed heating and cooling process for preparing a UHMWPE exhibiting a combination of properties including a creep resistance of less than 1% (under exposure to a temperature of 23° C. and a relative humidity of 50% for 24 hours under a compression of 1000 psi) without sacrificing tensile and flexural properties. U.K. Patent Application GB 2 180 815 A discloses a packaging method where a medical device which is sealed in a sterile bag, after radiation/sterilization, is hermetically sealed in a wrapping member of oxygen-impermeable material together with a deoxidizing agent for prevention of post-irradiation oxidation.
U.S. Pat. No. 5,153,039 relates to a high density polyethylene article with oxygen barrier properties. U.S. Pat. No. 5,160,464 relates to a vacuum polymer irradiation process.
SUMMARY OF THE INVENTION
The present invention relates to a method for providing a polymeric material, such as UHMWPE, with superior oxidation resistance upon irradiation. For the purpose of illustration, UHMWPE will be used as an example to describe the invention. However, all the theories and processes described hereafter should also apply to other polymeric materials such as polypropylene, high density polyethylene, polyester, nylon, polyurethane and poly(methylmethacrylate) unless otherwise stated.
As stated above, while UHMWPE polymer is very stable and has very good resistance to aggressive media except for strong oxidizing acids. Upon sterilization radiation, free radicals are formed which cause UHMWPE to become activated for chemical reactions and physical changes. Possible chemical reactions include reacting with oxygen, water, body fluids, and other chemical compounds while physical changes include density, crystallinity, color, and other physical properties. In the present invention a new sterilization radiation process greatly reduces the adverse effects caused by a conventional radiation process. Furthermore, this new sterilization process does not employ stabilizers, antioxidants, or any other chemical compounds which may have potential adverse effects in biomedical or orthopedic applications.
In the sterilization process of the present invention, a polymeric orthopedic implant component to be sterilized by radiation does not contain oxidants, such as oxygen or water (or moisture), or free radicals. This may be accomplished by obtaining a raw material for the implant manufactured under a special process as described herein and forming a part of the invention.
The finished polymeric orthopedic component is then sealed in an oxidant-free atmosphere. This oxidant-free atmosphere is maintained during radiation. The radiated polymeric component is then subjected to a heat treatment to cross-link all the free radicals within themselves. During this treatment, the condition of oxidant-free atmosphere is maintained. The irradiated, heat treated plastic component is now ready to use. Exposure to oxygen or moisture will not cause oxidation. The oxidation resistance to any oxidizing agent is similar to that of the unirradiated virgin polymer.
It is therefore an object of the invention to provide a polymeric orthopedic implant having superior oxidation resistance after irradiation.
It is still another object of the invention to provide a method for manufacturing such an implant from the resin powder thereof through the final sterilization step so that the implant may thereafter be exposed to air without degradation due to oxidation.
These and other objects are achieved by a method for producing a polymeric medical implant including the steps of placing the polymeric resin in a sealed container and removing a substantial portion of the oxygen from the container. After a predetermined time, the container is repressurized with an inert gas such as nitrogen, argon, helium or neon. The resin is thereafter transferred to a forming device which normally melts and forms the resin in an oxygen reduced atmosphere to produce a polymeric raw material. The polymeric raw material, such as UHMWPE is then machined to an implant such as a tibial tray or a liner for an acetabular cup. The finished part is then sealed into a package in an oxygen reduced atmosphere. The package is of an air-tight nature to prevent oxygen or moisture from entering after the package is sealed. The then packaged implant is radiation sterilized and then heat treated for the predetermined time and temperature sufficient to form cross-links between free radicals of the neighboring polymeric chains. This prevents further oxidation once the implant is removed from the package.
In general, the implant is heated for at least 48 hours at a temperature of about 37° C. to about 70° C. and preferably for 144 hours at 50° C.
DESCRIPTION OF THE PREFERRED EMBODIMENT
In the preferred method, a raw polymeric material such as UHMWPE is obtained by, for example, ram extrusion, compression molding, or other forming processes. These methods use virgin polymer powder as a starting material. However, virgin polymer resin powder may contain air or moisture, which may exist in the resin micro-structure or simply deposited on the resin surfaces. If air or moisture is not removed from resin powder prior to the forming process, it can be trapped in the plastic matrix after forming and can not escape. This is true even with the use of vacuum or gas flushing techniques. During the sterilization radiation process, the trapped air or moisture or both will react with free radicals generated in the plastic to cause oxidation. The trapped moisture can also absorb radiation energy and dissociate into oxygen and hydroxyl free radicals which will also react with the plastic to cause oxidation. Therefore, by removing air and moisture prior to the forming process, oxidation during sterilization radiation can be avoided.
The preferred method for eliminating air and moisture is to apply a vacuum of less than 3" of mercury (76 torr) to the polymer resin for a prescribed time to reduce the levels of air and moisture to a minimal or acceptable value. The level for oxygen is preferably 0.5% (volume by volume and no more than 1%). The moisture level is preferably 10% of relative humidity (and no more than 20% relative humidity). Then sufficient amounts of deoxidizing agents, such as oxygen absorbents and moisture desiccants, are placed together with the polymer resin in a sealed container to reduce the levels of air and moisture to the minimal or acceptable value. An example of an oxygen absorbent is AGELESS® which is an iron oxide compound and commercially available from Cryovac Division, W. R. Grace & Co., Duncan, S.C. An example of moisture desiccant is silica gel which is commercially available. These materials are placed with the resin in the sealed container for approximately 10 hours. Alternately, or in combination, an inert gas, such as nitrogen, argon, helium or neon is used to flush the container, holding the polymer resin powder, until the levels of air and moisture are reduced to the accepted value. Of course, any combination of the above methods can also be used.
In order to ensure a raw material for an orthopedic implant with no oxygen, not only must the UHMWPE resin powder be free of air and moisture, but the entire forming operation of, for example, ram extrusion, compression molding, or other forming process should be carried out in an inert or low oxygen atmosphere as well. During the forming process, due to high temperature and high pressure applied in the process, UHMWPE polymer chains may be broken to generate free radicals and cross-links. While cross-links generated in the forming process have no adverse effects on material properties, the free radicals produced, as described above, can react with air or other oxidants. Therefore, it is important to maintain the inert atmosphere during the forming process to minimize oxidation.
Any free radicals generated should be eliminated as soon as the forming process is completed by annealing. If the formed UHMWPE contains free radicals and is exposed to air or other oxidants after the forming process, oxidation will occur. The polymer should be annealed at an elevated temperature in an inert atmosphere for a prescribed time. This is because the rate of free radical reactions (reactions 10 through 12) increase with increasing temperature, according to the following general expressions: ##EQU1##
Compared to room temperature, an elevated temperature not only increases the reaction rate constants, k1, and k2, but also helps free radicals r. and P. to migrate in the plastic matrix to meet other neighboring free radicals for cross-linking reactions. In general, the desired elevated temperature is between the room temperature and the melting point of the polymer. For UHMWPE, this temperature range is between about 25° C. and about 140° C. However, the preferred annealing temperature range is from about 37° C. to about 135° C. The preferred time and temperature is 130° C. for 20 hours with the minimum annealing time being about 4 hours (requiring a temperature at the high end of the range). It is to be noted that the higher the temperature used, the shorter the time period needed to combine free radicals. Additionally, due to the high viscosity of an UHMWPE melt, the formed UHMWPE often contains residual (internal) stress caused by incomplete relaxation during the cooling process, which is the last step of the forming process. The annealing process described herein will also help to eliminate or reduce the residual stress. A residual stress contained in a plastic matrix can cause dimensional instability and is in general undesirable.
In applications such as for orthopedic implants, the formed UHMWPE is further machined into desired shapes. In general, the machining is done at room temperature and no damage to the plastic will occur. However, certain machine tools, when operated at a high speed, may generate local heat and cause thermal breakdown of UHMWPE polymer chains. In this case, the above described annealing process may be employed to eliminate any newly formed free radicals prior to packaging.
After machining, the polymeric component is packaged in an air tight package in an oxidant-free atmosphere. Thus, all air and moisture must be removed from the package prior to the sealing step. Machines to accomplish this are commercially available, such as from Orics Industries Inc., College Point, N.Y. which flush the package with a chosen inert gas, vacuum the container, flush the container for the second time, and then heat seal the container with a lid. In general, less than 0.5% (volume by volume) oxygen concentration can be obtained consistently. An example of a suitable oxidant impermeable (air tight) packaging material is polyethylene terephthalate (PET). Other examples of oxidant impermeable packaging material is poly(ethylene vinyl alcohol) and aluminum foil, whose oxygen and water vapor transmission rates are essentially zero. All these materials are commercially available. Several other suitable commercial packaging materials utilize a layer structure to form a composite material with superior oxygen and moisture barrier properties. An example of this type is a layered composite comprised of poly-propylene/poly(ethylene vinyl alcohol)/polypropylene.
In general, the sterilization radiation step for the packaged implant may take a few hours to complete. As described above, it is imperative that during this time period, the transmission of oxidants, such as oxygen and moisture, into the package be kept to a minimal or at an acceptable value to avoid oxidation.
Following sterilization radiation, a heat treatment step should be performed in an inert atmosphere and at an elevated temperature to cause free radicals to form cross-links without oxidation. If proper packaging materials and processes are used and oxidant transmission rates are minimal, then the oxidant-free atmosphere can be maintained in the package and a regular oven with air circulation can be used for heat treatment after sterilization. To absolutely ensure that no oxidants leak into the package, the oven may be operated under a vacuum or purged with an inert gas. In general, if a higher temperature is used, a shorter time period is required to achieve a prescribed level of oxidation resistance and cross-linking. In many cases, the relationship between the reaction temperature and the reaction rate follows the well-known Arrhennius equation:
k.sub.1, or k.sub.2 =A*exp (ΔH/T)                    (14)
where k1 and k2 are reaction rate constants from reactions 13 and 14 A is a reaction dependent constant ΔH is activation energy of reaction T is absolute temperature (K)
However, the temperature should not exceed the distortion temperature of either the packaging material or the plastic components. For UHMWPE, the temperature range is between about 25° C. and about 140° C. However, considering the distortion of the packaging material, the preferred temperature is 37° C. to 70° C.
It is very important to ensure that the number of free radicals has been reduced to a minimal or an accepted level by the heat treatment. This is because the presence of an oxidant causes not only the oxidation of pre-existing free radicals, but also the formation of new free radicals via reactions 2 through 7. When the number of free radicals grows, the extent of oxidation and the oxidation rate will increase according to the following equations: ##EQU2##
Where free radicals r. and P. can grow in number in the presence of oxidants and in turn increase the oxidation rates. It is also to be noted that the oxidation reaction rate constants k3 and k4 increase with increasing temperature, similar to k1 and k2. Therefore, to determine if a certain level of residual free radicals is acceptable or not, it is required to evaluate specific material properties after the plastic sample is stored or aged at the application temperature for a time period which is equal to or longer than the time period intended for the application of the plastic component. An alternative to the method to assess the aging effect is to raise the aging temperature of the plastic sample for a shorter time period. This will increase the reaction rate constants k3 and k4 significantly and shorten the aging time. It has been found that an acceptable level of residual free radicals is 1.0×1017 /g for UHMWPE use for orthopedic implants. After heat treatment, the irradiated packaged plastic component is now ready to use. The package can be opened and exposed to air or moisture without causing oxidation. The oxidation resistance of the sterilized plastic component to other oxidants is similar to that of the virgin, unirradiated polymer.
Sample Preparation
A surgical grade UHMWPE rod produced by ram extrusion was machined into samples of desirable shapes. Four sets of samples were prepared using these machined samples by the following methods:
Method A: an UHMWPE sample as machined and unirradiated
Method B: An UHMWPE sample was heat sealed in a glycol-modified polyethylene terephthalate (PETG, made by Eastman Plastics, Inc., Kingsport, Tenn.) blister in air with an aluminum lid of 0.1 mm in thickness. The sealed blister containing the UHMWPE sheet was sterilized by irradiation of gamma-rays in a dose of 2.5 Mrad. The package was then opened and exposed to room air.
Method C: An UHMWPE sample was placed in a PETG blister and heat sealed in dry nitrogen with an aluminum lid of 0.1 mm in thickness by the Orics Vacuum Gas Flush Heat Seal Machine (Model SLS-VGF-100M for modified atmosphere packaging, made by Orics Industries Inc., College Point, N.Y.) which went through the following cycles: i) nitrogen gas (moisture-free) flush for five seconds ii) vacuum to a pressure of equal to or below 3 inches of mercury iii) nitrogen gas flush (moisture-free) for five seconds iv) heat seal
The oxygen concentration in the sealed blister was measured by a Mocon Oxygen Analyzer to be 0.325% (volume by volume). The sealed blister containing the UHMWPE sample was sterilized by irradiation of gamma-rays in a dose of 2.5 Mrad. The oxygen concentration in the sealed blister after sterilization radiation was measured to be 0.350%. The package was then opened and exposed to room air.
Method D:
Same as Method C, except that after gamma-ray irradiation, the sealed blister containing the UHMWPE sample was heat treated at 50° C. for 144 hours in an oven, then transferred from the oven to room temperature for cooling. After the package was cooled to room temperature, the oxygen concentration was measured by a Mocon Oxygen Analyzer to be 0.360%. The package was then opened and exposed to room air.
Samples prepared by the above methods were used in the following examples for evaluation.
Example 1
Two sets of 1-mm-thick UHMWPE sheets prepared by Methods A through D above were oven aged in air at 80° C. for 11 and 23 days respectively. After these sheets were cooled in room temperature, a thin film specimen of about 100 microns in thickness was cut from each of the 1-mm-thick aged UHMWPE sheets and placed in an IR window for a standard FTIR (A Nicolet 710 FTIR system was used) transmission run. A total of 32 spectra (scans) were collected and averaged. To determine the extent of oxidation, the IR absorption peaks in the frequency range of between 1660 and 1800 cm-1, corresponding to carbonyl (C-O) functional groups, were integrated for the peak area. The peak area is proportional to the amount of oxidized UHMWPE in the specimen. To correct for difference in specimen thickness, the integrated peak area was then normalized to the specimen thickness, by dividing by the area of the 1463 cm-1 (methyl) peak which is proportional to the specimen thickness. The obtained ratio was defined as oxidation index. A third set of 1-mm-thick UHMWPE sheets prepared by methods A through D, but without oven aging, were also evaluated by the same FTIR method for comparison. Oxidation indices obtained are shown in Table 1:
              TABLE 1                                                     
______________________________________                                    
Sample              Oxidation Index                                       
______________________________________                                    
Method A/not oven aged                                                    
                    ca. 0.                                                
Method A/11 day oven aging                                                
                    ca. 0.                                                
Method A/23 day oven aging                                                
                    ca. 0.                                                
Method B/not oven aged                                                    
                    0.02                                                  
Method B/11 day oven aging                                                
                    0.06                                                  
Method B/23 day oven aging                                                
                    0.11                                                  
Method C/not oven aged                                                    
                    0.01                                                  
Method C/11 day oven aging                                                
                    0.04                                                  
Method C/23 day oven aging                                                
                    0.08                                                  
Method D/not oven aged                                                    
                    0.01                                                  
Method D/11 day oven aging                                                
                    0.01                                                  
Method D/23 day oven aging                                                
                    0.01                                                  
______________________________________                                    
From Table 1 results, it can be seen that the unirradiated UHMWPE sample (Method A) was free of oxidation (below the FTIR detectable level), even after 23 days of oven aging in air at 80° C. On the other hand, the UHMWPE sample irradiated in air (Method B) showed considerable oxidation and the extent of oxidation (as indicated by the oxidation index) increased with increasing aging time. After 23 days of oven aging, the oxidation index reached 0.11. For the UHMWPE sample irradiated in nitrogen (Method C), the initial oxidation index before oven aging was 0.01 which was not significant. However, during the oven aging, the oxidation index increased to 0.04 for 11 days and 0.08 for 23 days respectively. The results indicate that while irradiation in an inert atmosphere is an improvement over oxidation in air, the irradiated plastic component will oxidize further over time once it is exposed to air or other oxidants. In contrast, the UHMWPE sample irradiated in nitrogen followed by heat treatment at 50° C. for 144 hours (Method D), showed an initial oxidation index of only 0.01 which did not increase after 11 or 23 days of oven aging, indicating that this sample has superior oxidation resistance than the samples prepared by Method B or C.
Example 2
Two sets of 1-mm-thick UHMWPE sheets prepared by Methods B through D cited in the Sample Preparation were oven aged in air at 80° C. for 11 and 23 days respectively. After these sheets were cooled in room temperature, six tensile specimens with a dumbbell shape according to ASTM D638 (Type IV) were cut from each of the 1-mm-thick aged UHMWPE sheets. A standard tensile test was performed for each specimens at a speed of 2 inches/min. Another set of 1-mm-thick UHMWPE sheets prepared by Methods B through D cited in the Sample Preparation, but without oven aging, were also evaluated by the same tensile test method for comparison. Tensile breaking strength results (average of six tests for each condition) are shown in Table 2:
              TABLE 2                                                     
______________________________________                                    
Sample            Tensile Breaking Strength, psi                          
______________________________________                                    
Method B/not oven aged                                                    
                  6510                                                    
Method B/11 day oven aging                                                
                  5227                                                    
Method B/23 day oven aging                                                
                  3192                                                    
Method C/not oven aged                                                    
                  6875                                                    
Method C/11 day oven aging                                                
                  6400                                                    
Method C/23 day oven aging                                                
                  6004                                                    
Method D/not oven aged                                                    
                  6941                                                    
Method D/11 day oven aging                                                
                  7113                                                    
Method D/23 day oven aging                                                
                  6904                                                    
______________________________________                                    
From Table 2, tensile breaking strength shows the most deterioration for the sample irradiated in air (Method B). The sample irradiated in nitrogen (Method C) shows some improvement over the sample prepared by Method B. However, the decrease in tensile breaking strength upon oven aging still occurs. In contrast, the sample irradiated in nitrogen followed by heat treatment (50° C. for 144 hours, Method D), shows no change in tensile breaking strength, indicating a superior oxidation resistance.
Example 3
Two sets of 1-mm-thick UHMWPE sheets prepared by Methods B and Method D cited in the Sample Preparation were oven aged in air at 80° C. for 11 and 23 days respectively. After these sheets were cooled in room temperature, samples cut from sheets were characterized by a high temperature gel permeation chromatograph (GPC) column for molecular weight distribution. The samples were dissolved in hot trichlorobenzene (TCB). They were then run in the aforementioned solvent at 1.2 ml/min. using a Jordi Gel Mixed Bed Column, 50 cm×10.0 mm ID., at a column oven temperature of 145° C. on the Waters 150C Chromatograph. The injection size was 250 uL of a 0.1% solution. An antioxidant (N-phenyl-2-naphthylamine) was added to all high temperature GPC samples to prevent polymer deterioration.
Prior to sample runs, the column was calibrated using narrow MW polystyrene standards. Since the samples were only partially soluble in the solvent due to cross-linking, the so-determined molecular weight distribution was for the soluble portion only. To determine the extent of cross-linking (solubility), a two hundred milligram sample cut from sheets were dissolved in 100 cc of 1,2,4-trichlorobenzene. Each sample was then heated to approximately 170° C. with N-phenyl-2-naphthylamine antioxidant added for 6 hours. The samples were then hot filtered at approximately 170° C. using separate preweighed high temperature filters for each sample.
After filtration, the filters were cooled to room temperature and washed individually with dichloromethane. They were then placed in a convection oven at 105° C. for 6 hours to dry and then reweighed. The weight fraction of the undissolved (cross-linked) portion was then determined based upon the initial weight of 200 mg. To determine the low molecular weight fraction present in each sample, the weight fraction of molecular weight below 105 in the soluble portion, determined by GPC, was multiplied by the percent solubility to give weight percent of low molecular weight fraction in each sample. Results are shown in Table 3:
              TABLE 3                                                     
______________________________________                                    
         Weight Percent of                                                
                      Percent   Weight Percent of                         
         Soluble Portion                                                  
                      Solubility                                          
                                Entire Sample                             
Sample   Below 10.sup.5                                                   
                      in Solvent                                          
                                Below 10.sup.5                            
______________________________________                                    
Method B/                                                                 
         28.0         98.2      27.5                                      
without                                                                   
oven aging                                                                
Method B/                                                                 
         36.2         100.0     36.2                                      
11 day                                                                    
oven aging                                                                
Method B/                                                                 
         48.1         100.0     48.1                                      
23 day                                                                    
oven aging                                                                
Method D/                                                                 
         22.7         80.9      18.4                                      
without                                                                   
oven aging                                                                
Method D/                                                                 
         20.5         73.6      15.1                                      
11 day                                                                    
oven aging                                                                
Method D/                                                                 
         24.2         74.7      18.1                                      
23 day                                                                    
oven aging                                                                
______________________________________                                    
From Table 3, it can be seen that the sample made by Method D contains more cross-linking (i.e. less soluble) than one made by Method B. Upon oven aging, the low molecular weight fraction (defined as below 105) in the sample made by Method B increases from 0.275 to 0.481 while that of the sample made by Method D remains virtually unchanged at about 0.18 after 23 days of oven aging. The increase in low molecular weight fraction was due to chain scission caused by oxidative reactions. The results indicate that the process of method D can produce an irradiated polymer with a superior oxidation resistance.
Example 4
UHMWPE samples of 0.5 inch cubes prepared by Methods B and Method D cited in the Sample Preparation were evaluated for deformation under load (creep resistance). Testing procedures according to ASTM D 621 (A) (24 hr/23° C./1000 psi/90 min recovery) were used. Results are summarized in Table 4:
              TABLE 4                                                     
______________________________________                                    
             Deformation under                                            
Sample       Load, %                                                      
______________________________________                                    
Method B     0.80                                                         
Method D     0.60                                                         
______________________________________                                    
From Table 4, it is concluded that the sample prepared by Method D, the invention, possesses a superior creep resistance (0.6%) to one prepared by Method B (0.8%).
Example 5
Two 1-mm-thick UHMWPE samples were annealed in a oven filled with air and dry nitrogen (oxygen concentration is below 0.2%) respectively at 130° C. for 20 hours in order to remove residual stress on the samples. After the sheets were cooled to room temperature in the oven, they were removed from the oven and cut into dumbbell shaped tensile specimens (ASTM D 638, Type V) for evaluation. A standard tensile test according to ASTM D 638 was performed at a speed of 2 inches/min for each of six specimens annealed in air and in dry nitrogen respectively. Results are shown in Table 5:
              TABLE 5                                                     
______________________________________                                    
                                    Toughness,                            
Sample    EAB, %   TYS, psi  TBS, psi                                     
                                    lbs-in/in.sup.3                       
______________________________________                                    
Air annealed                                                              
          414      3547      6257   10,210                                
Nitrogen  485      3517      8917   18,960                                
annealed                                                                  
______________________________________                                    
 Note:                                                                    
 EAB -- elongation at break                                               
 TYS -- tensile yield strength                                            
 TBS -- Tensile breaking strength                                         
From the above table, it is seen that the sample annealed in nitrogen exhibits a higher elongation at break, a higher tensile breaking strength, and a higher toughness, compared to one annealed in air, while the tensile yield strength is similar between the two samples. The results indicate that the sample annealed in nitrogen is more ductile than the one annealed in air. The loss of ductility in the sample annealed in air is due to oxidative chain scission.
To determine oxidation indices in these two samples, a thin film specimen of ca. 100 microns in thickness was cut from each of the 1-mm-thick annealed UHMWPE sheets and placed in an IR window for a standard FTIR (a Nicolet 710 FTIR system was used) transmission run, using the procedures and calculations employed in the Sample Preparation. Oxidation indices obtained are shown in Table 6.
              TABLE 6                                                     
______________________________________                                    
Sample          Oxidation Index                                           
______________________________________                                    
Air Annealed    0.10                                                      
Nitrogen Annealed                                                         
                ca. 0.0                                                   
______________________________________                                    
From the above results, it is seen that the UHMWPE sample annealed in air after ram extrusion showed significant oxidation due to free radicals generated in the forming process. In contrast, the UHMWPE sample annealed in nitrogen showed no oxidation (below the FTIR detectable level). It is concluded that annealing in nitrogen can prevent the polymer from oxidation and produce a polymer with superior ductility.
While several examples of the present invention have been described, it is obvious that many changes and modifications may be made thereunto, without departing from the spirit and scope of the invention.

Claims (41)

We claim:
1. A method for producing a medical implant formed from an olefinic material, the material having improved oxidation resistance comprising the steps of:
sealing the implant in an oxygen impermeable package in an oxygen reduced non-reactive atmosphere;
radiation sterilizing said packaged implant; and
heating said packaged implant for a predetermined time at a temperature of between about 37° C. and the melting point of said olefinic material to form cross-links between free radicals in neighboring polymeric chains.
2. The method for producing an implant set forth in claim 1 wherein said predetermined temperature is between about 37° C. and about 70° C.
3. The method for producing an implant as set forth in claim 2 wherein said predetermined time is at least forty eight hours.
4. The method for producing an implant as set forth in claim 3 wherein said predetermined temperature is 50° C. and said predetermined time is 144 hours.
5. The method for producing an implant as set forth in claim 1 wherein the polymeric material is ultra high molecular weight polyethylene having a molecular weight between 400,000 and 10,000,000.
6. The method for producing an implant as set forth in claim 5 wherein said predetermined temperature is 50° C. and said predetermined time is 144 hours.
7. The method for producing an implant as set forth in claim 1 wherein said radiation sterilization is performed by gamma, x-ray or electron beam radiation.
8. The method as set forth in claim 1 wherein said oxygen reduced atmosphere has no more than 1% oxygen.
9. The method for producing an implant as set forth in claim 8 wherein said oxygen reduced atmosphere is made up of a gas selected from the group consisting of nitrogen, helium, argon, and neon and a combination thereof.
10. The method for producing an implant as set forth in claim 8 wherein said reduced oxygen atmosphere is produced by a vacuum of less than 3 inches of mercury.
11. The method for producing an implant as set forth in claim 8 wherein said sealing in a reduced oxygen atmosphere is produced by first flushing said package with a gas selected from the group consisting of nitrogen, helium, argon and neon and a combination thereof, followed by applying a vacuum of less than 3 inches of mercury to said package, followed by flushing said package with a gas selected from said group and a combination thereof.
12. A method for producing a medical implant made from an olefinic material having a molecular weight of between 400,000 and 10,000,000 comprising the steps of:
forming the implant from the olefinic material;
packaging the formed implant in an inert atmosphere;
radiation sterilizing said packaged implant while maintaining said inert atmosphere; and
heating said packaged implant while maintaining said inert atmosphere for at least 48 hours at a temperature of about 37° C. to about 70° C.
13. The method for producing an implant as set forth in claim 12 wherein the olefinic material is ultra high molecular weight polyethylene.
14. The method for producing an implant as set forth in claim 12 wherein said predetermined temperature is 50° C. and said predetermined time is 144 hours.
15. The method as set forth in claim 12 wherein said oxygen reduced atmosphere has no more than 1% oxygen.
16. The method for producing an implant as set forth in claim 15 wherein said inert atmosphere is made up of a gas selected from the group consisting of nitrogen, helium, argon, and neon and a combination thereof.
17. The method for producing an implant as set forth in claim 15 wherein said inert atmosphere is produced by a vacuum of less than 3 inches of mercury.
18. The method as set forth in claim 12 wherein said heating step is performed in an inert atmosphere.
19. A method for producing a medical implant from an olefinic material having a molecular weight greater than 400,000 comprising the steps of:
sealing the implant in an oxygen impermeable package in an oxygen reduced atmosphere having an absence of agents which can react with free radicals in the polymeric chain;
radiation sterilizing said packaged implant; and
heating said sealed packaged implant for a predetermined time and temperature sufficient to form cross-links between free radicals in neighboring polymeric chains.
20. The method as set forth in claim 19 wherein said oxygen reduced atmosphere has no more than 1% oxygen.
21. The method for producing an implant as set forth in claim 20 wherein said oxygen reduced atmosphere is made up of a gas selected from the group consisting of nitrogen, helium, argon, and neon and a combination thereof.
22. The method for producing an implant as set forth in claim 20 wherein said oxygen reduced atmosphere is produced by a vacuum of less than 3 inches of mercury.
23. The method for producing an implant as set forth in claim 20 wherein said sealing in said oxygen reduced atmosphere is produced by first flushing said package with a gas selected from the group consisting of nitrogen, helium, argon and neon and a combination thereof, followed by applying a vacuum of less than 3 inches of mercury to said package, followed by flushing said package with a gas selected from said group and a combination thereof.
24. The method for producing an implant as set forth in claim 19 wherein the olefinic material is ultra high molecular weight polyethylene having a molecular weight between 400,000 and 10,000,000.
25. A method for producing a medical implant made from olefinic material having a molecular weight greater than 400,000 comprising the steps of:
sealing the implant in an oxygen impermeable package in an inert atmosphere;
radiation sterilizing said packaged implant; and
heating said packaged implant for at least four hours at a temperature of between 37° C. and the melting point of said olefinic material to form cross-links between free radicals in neighboring polymeric chains.
26. The method as set forth in claim 25 wherein said inert atmosphere has no more than 1% oxygen.
27. The method for producing an implant as set forth in claim 26 wherein said inert atmosphere is made up of a gas selected from the group consisting of nitrogen, helium, argon, and neon and a combination thereof.
28. The method for producing an implant as set forth in claim 26 wherein said inert atmosphere is produced by a vacuum of less than 3 inches of mercury.
29. The method for producing an implant as set forth in claim 26 wherein said sealing in said inert reactive atmosphere is produced by first flushing said package with a gas selected from the group consisting of nitrogen, helium, argon and neon and a combination thereof, followed by applying a vacuum of less than 3 inches of mercury to said package, followed by flushing said package with a gas selected from said group and a combination thereof.
30. The method for producing an implant as set forth in claim 25 wherein the olefin material is ultra high molecular weight polyethylene having a molecular weight between 400,000 and 10,000,000.
31. A method for producing a medical implant formed from an olefinic material comprising the steps of:
forming the implant from an olefinic material having a molecular weight of 400,000 to 10,000,000;
sealing the formed implant in an oxygen impermeable package in a substantially oxygen-free atmosphere;
radiation sterilizing said packaged implant; and
heating said sealed package implant for a predetermined time and temperature sufficient to form cross-links between free radicals in neighboring polymeric chains.
32. The method for producing an implant as set forth in claim 31 wherein said atmosphere contains less than 1% oxygen.
33. The method for producing an implant as set forth in claim 32 wherein said substantially oxygen free atmosphere is made up of a gas selected from the group consisting of nitrogen, helium, argon, and neon and a combination thereof.
34. The method for producing an implant as set forth in claim 32 wherein said substantially oxygen free atmosphere is produced by placing deoxidizing agents in said package prior to sealing.
35. The method for producing an implant as set forth in claim 32 wherein the polymeric material is ultra high molecular weight polyethylene.
36. A method for producing a sterile polymeric medical implant having improved oxidation resistance comprising the steps of:
sealing a polymeric medical implant in an oxygen-free atmosphere contained in a container comprising an oxygen impermeable composition;
sterilizing said implant by irradiation; and
heating said package and implant at a sufficient temperature and for a sufficient time to inactivate any residual free radicals and/or free radical precursors.
37. The method of claim 36 wherein said implant is formed from a polymeric article which has been freed of occluded oxygen gas.
38. The method of claim 36 wherein said free radical precursors include peroxy and hydroperoxy groups on the polymer chains.
39. The method of claim 36 wherein said oxygen free atmosphere comprises an inert gas or a vacuum.
40. The method of claim 39 wherein said inert gas contains no more than 1% oxygen.
41. The method of claim 39 wherein said atmosphere comprises a vacuum of not more than 3 inches of Mercury.
US08/070,074 1993-06-01 1993-06-01 Non-oxidizing polymeric medical implant Expired - Lifetime US5414049A (en)

Priority Applications (26)

Application Number Priority Date Filing Date Title
US08/070,074 US5414049A (en) 1993-06-01 1993-06-01 Non-oxidizing polymeric medical implant
DE9490446U DE9490446U1 (en) 1993-06-01 1994-04-26 Non-oxidizing polymeric medical implant
EP94912052A EP0701453B1 (en) 1993-06-01 1994-04-26 Non-oxidizing polymeric medical implant
CA002162927A CA2162927C (en) 1993-06-01 1994-04-26 Non-oxidizing polymeric medical implant
AU64364/94A AU684500B2 (en) 1993-06-01 1994-04-26 Non-oxidizing polymeric medical implant
JP7500438A JP2836965B2 (en) 1993-06-01 1994-04-26 Non-oxidizing polymer medical implant
EP00200859A EP1005872B1 (en) 1993-06-01 1994-04-26 Non-oxidizing polymeric medical implant
PCT/IB1994/000083 WO1994027651A1 (en) 1993-06-01 1994-04-26 Non-oxidizing polymeric medical implant
EP05017610A EP1598086A2 (en) 1993-06-01 1994-04-26 Non-oxidizing polymeric medical implant
DE69413395T DE69413395T2 (en) 1993-06-01 1994-04-26 NON-OXYDING MEDICAL POLYMER IMPLANT
AT94912052T ATE171078T1 (en) 1993-06-01 1994-04-26 NON-OXIDIZING MEDICAL POLYMER IMPLANT
EP98103006A EP0847765B1 (en) 1993-06-01 1994-04-26 Non-oxidizing polymeric medical implant
DE69425838T DE69425838T2 (en) 1993-06-01 1994-04-26 Non-oxidizing, medical polymer implant
DE69434462T DE69434462T2 (en) 1993-06-01 1994-04-26 Non-oxidizing medical polymer implant
ES94912052T ES2122260T3 (en) 1993-06-01 1994-04-26 STAINLESS POLYMERICAL MEDICAL IMPLANT.
AT98103006T ATE196095T1 (en) 1993-06-01 1994-04-26 NON-OXIDIZING MEDICAL POLYMER IMPLANT
AT00200859T ATE302032T1 (en) 1993-06-01 1994-04-26 NON-OXIDIZING MEDICAL POLYMER IMPLANT
US08/320,705 US5449745A (en) 1993-06-01 1994-10-07 Non-oxidizing polymeric medical implant
US08/404,663 US5543471A (en) 1993-06-01 1995-03-15 Non-oxidizing polymeric medical implant
US08/439,028 US5650485A (en) 1993-06-01 1995-05-11 Non-oxidizing polymeric medical implant
US08/733,067 US5728748A (en) 1993-06-01 1996-10-16 Non oxidizing polymeric medical implant
US09/012,345 US6174934B1 (en) 1993-06-01 1998-01-23 Non-oxidizing polymeric medical implant
US09/604,868 US6372814B1 (en) 1993-06-01 2000-06-28 Non-oxidizing polymeric medical implant
US10/041,118 US6664308B2 (en) 1993-06-01 2002-01-08 Non-oxidizing polymeric medical implant
US10/461,636 US6818020B2 (en) 1993-06-01 2003-06-13 Non-oxidizing polymeric medical implant
US10/935,510 US20050059750A1 (en) 1993-06-01 2004-09-07 Non-oxidizing polymeric medical implant

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/070,074 US5414049A (en) 1993-06-01 1993-06-01 Non-oxidizing polymeric medical implant

Related Child Applications (2)

Application Number Title Priority Date Filing Date
US08/320,705 Division US5449745A (en) 1993-06-01 1994-10-07 Non-oxidizing polymeric medical implant
US08/404,663 Division US5543471A (en) 1993-06-01 1995-03-15 Non-oxidizing polymeric medical implant

Publications (1)

Publication Number Publication Date
US5414049A true US5414049A (en) 1995-05-09

Family

ID=22092961

Family Applications (10)

Application Number Title Priority Date Filing Date
US08/070,074 Expired - Lifetime US5414049A (en) 1993-06-01 1993-06-01 Non-oxidizing polymeric medical implant
US08/320,705 Expired - Fee Related US5449745A (en) 1993-06-01 1994-10-07 Non-oxidizing polymeric medical implant
US08/404,663 Expired - Lifetime US5543471A (en) 1993-06-01 1995-03-15 Non-oxidizing polymeric medical implant
US08/439,028 Expired - Lifetime US5650485A (en) 1993-06-01 1995-05-11 Non-oxidizing polymeric medical implant
US08/733,067 Expired - Lifetime US5728748A (en) 1993-06-01 1996-10-16 Non oxidizing polymeric medical implant
US09/012,345 Expired - Fee Related US6174934B1 (en) 1993-06-01 1998-01-23 Non-oxidizing polymeric medical implant
US09/604,868 Expired - Fee Related US6372814B1 (en) 1993-06-01 2000-06-28 Non-oxidizing polymeric medical implant
US10/041,118 Expired - Fee Related US6664308B2 (en) 1993-06-01 2002-01-08 Non-oxidizing polymeric medical implant
US10/461,636 Expired - Fee Related US6818020B2 (en) 1993-06-01 2003-06-13 Non-oxidizing polymeric medical implant
US10/935,510 Abandoned US20050059750A1 (en) 1993-06-01 2004-09-07 Non-oxidizing polymeric medical implant

Family Applications After (9)

Application Number Title Priority Date Filing Date
US08/320,705 Expired - Fee Related US5449745A (en) 1993-06-01 1994-10-07 Non-oxidizing polymeric medical implant
US08/404,663 Expired - Lifetime US5543471A (en) 1993-06-01 1995-03-15 Non-oxidizing polymeric medical implant
US08/439,028 Expired - Lifetime US5650485A (en) 1993-06-01 1995-05-11 Non-oxidizing polymeric medical implant
US08/733,067 Expired - Lifetime US5728748A (en) 1993-06-01 1996-10-16 Non oxidizing polymeric medical implant
US09/012,345 Expired - Fee Related US6174934B1 (en) 1993-06-01 1998-01-23 Non-oxidizing polymeric medical implant
US09/604,868 Expired - Fee Related US6372814B1 (en) 1993-06-01 2000-06-28 Non-oxidizing polymeric medical implant
US10/041,118 Expired - Fee Related US6664308B2 (en) 1993-06-01 2002-01-08 Non-oxidizing polymeric medical implant
US10/461,636 Expired - Fee Related US6818020B2 (en) 1993-06-01 2003-06-13 Non-oxidizing polymeric medical implant
US10/935,510 Abandoned US20050059750A1 (en) 1993-06-01 2004-09-07 Non-oxidizing polymeric medical implant

Country Status (9)

Country Link
US (10) US5414049A (en)
EP (4) EP0701453B1 (en)
JP (1) JP2836965B2 (en)
AT (3) ATE196095T1 (en)
AU (1) AU684500B2 (en)
CA (1) CA2162927C (en)
DE (4) DE9490446U1 (en)
ES (1) ES2122260T3 (en)
WO (1) WO1994027651A1 (en)

Cited By (140)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5611310A (en) * 1995-01-18 1997-03-18 Honda Giken Kogyo Kabushiki Kaisha Driving force-calculating system and control system incorporating same for automotive vehicles
WO1997029787A1 (en) * 1996-02-14 1997-08-21 Biomet, Inc. Method for reducing the number of free radicals present in ultrahigh molecular weight polyethylene orthopedic components
US5674290A (en) * 1995-04-05 1997-10-07 Li; Shu-Tung Water-stabilized biopolymeric implants
WO1998016258A1 (en) * 1996-10-15 1998-04-23 The Orthopaedic Hospital Wear resistant surface-gradient cross-linked polyethylene
US5753182A (en) * 1996-02-14 1998-05-19 Biomet, Inc. Method for reducing the number of free radicals present in ultrahigh molecular weight polyethylene orthopedic components
US5879400A (en) * 1996-02-13 1999-03-09 Massachusetts Institute Of Technology Melt-irradiated ultra high molecular weight polyethylene prosthetic devices
US6017975A (en) * 1996-10-02 2000-01-25 Saum; Kenneth Ashley Process for medical implant of cross-linked ultrahigh molecular weight polyethylene having improved balance of wear properties and oxidation resistance
WO2000011980A1 (en) * 1998-08-27 2000-03-09 Gardon John L Non-allergenic medical and health care devices made from crosslinked synthetic elastomers
WO2000062717A1 (en) 1999-04-21 2000-10-26 Howmedica Osteonics Corp. Selectively cross-linked polyethylene orthopedic devices
US6143232A (en) * 1999-07-29 2000-11-07 Bristol-Meyers Squibb Company Method of manufacturing an articulating bearing surface for an orthopaedic implant
EP1072277A1 (en) * 1999-07-29 2001-01-31 Depuy Orthopaedics, Inc. Gamma irradiated heat treated implant for mechanical strength
EP1072276A1 (en) * 1999-07-29 2001-01-31 Depuy Orthopaedics, Inc. Low temperature pressure stabilisation of implant component
US6228900B1 (en) 1996-07-09 2001-05-08 The Orthopaedic Hospital And University Of Southern California Crosslinking of polyethylene for low wear using radiation and thermal treatments
US6245276B1 (en) 1999-06-08 2001-06-12 Depuy Orthopaedics, Inc. Method for molding a cross-linked preform
US6281264B1 (en) 1995-01-20 2001-08-28 The Orthopaedic Hospital Chemically crosslinked ultrahigh molecular weight polyethylene for artificial human joints
EP1129731A2 (en) 2000-02-29 2001-09-05 Howmedica Osteonics Corp. Compositions, processes and methods of improving the wear resistance of prosthetic medical devices
US6290726B1 (en) 2000-01-30 2001-09-18 Diamicron, Inc. Prosthetic hip joint having sintered polycrystalline diamond compact articulation surfaces
WO2001080778A1 (en) * 2000-04-27 2001-11-01 The Orthopaedic Hospital Oxidation-resistant and wear-resistant polyethylenes for human joint replacements and methods for making them
US20020007219A1 (en) * 1996-02-13 2002-01-17 Merrill Edward W. Radiation and melt treated ultra high molecular weight polyethylene prosthetic devices
US6355215B1 (en) 1999-03-10 2002-03-12 Implex Corp. Wear-resistant olefinic medical implant and thermal treatment container therefor
US6365089B1 (en) 1999-09-24 2002-04-02 Zimmer, Inc. Method for crosslinking UHMWPE in an orthopaedic implant
US6395799B1 (en) 2000-02-21 2002-05-28 Smith & Nephew, Inc. Electromagnetic and mechanical wave energy treatments of UHMWPE
US6402787B1 (en) 2000-01-30 2002-06-11 Bill J. Pope Prosthetic hip joint having at least one sintered polycrystalline diamond compact articulation surface and substrate surface topographical features in said polycrystalline diamond compact
US6410877B1 (en) 2000-01-30 2002-06-25 Diamicron, Inc. Methods for shaping and finishing prosthetic joint components including polycrystalline diamond compacts
US6425922B1 (en) 2000-01-30 2002-07-30 Diamicron, Inc. Prosthetic hip joint having at least one sintered polycrystalline diamond compact articulation surface
US6432349B1 (en) 1999-06-29 2002-08-13 Zimmer, Inc. Process of making an articulating bearing surface
US20020156536A1 (en) * 1996-02-13 2002-10-24 Harris William H. Polyethylene hip joint prosthesis with extended range of motion
US6494918B1 (en) 2000-01-30 2002-12-17 Diamicron, Inc. Component for a prosthetic joint having a diamond load bearing and articulation surface
US20030019106A1 (en) * 2001-04-22 2003-01-30 Diamicron, Inc. Methods for making bearings, races and components thereof having diamond and other superhard surfaces
US6514289B1 (en) 2000-01-30 2003-02-04 Diamicron, Inc. Diamond articulation surface for use in a prosthetic joint
US20030050703A1 (en) * 2000-07-31 2003-03-13 Harris William H. Acetabular components that decrease risks of dislocation
US6547828B2 (en) 2001-02-23 2003-04-15 Smith & Nephew, Inc. Cross-linked ultra-high molecular weight polyethylene for medical implant use
US20030125513A1 (en) * 2001-12-12 2003-07-03 Richard King Orthopaedic device for implantation in the body of an animal and method for making the same
US6596225B1 (en) 2000-01-31 2003-07-22 Diamicron, Inc. Methods for manufacturing a diamond prosthetic joint component
WO2003059200A1 (en) * 2002-01-04 2003-07-24 Massachusetts General Hospital A high modulus crosslinked polyethylene with reduced residual free radical concentration prepared below the melt
US20030144741A1 (en) * 2002-01-28 2003-07-31 Richard King Composite prosthetic bearing having a crosslinked articulating surface and method for making the same
US6627141B2 (en) 1999-06-08 2003-09-30 Depuy Orthopaedics, Inc. Method for molding a cross-linked preform
US6626945B2 (en) 2000-03-14 2003-09-30 Chondrosite, Llc Cartilage repair plug
US6632246B1 (en) 2000-03-14 2003-10-14 Chondrosite, Llc Cartilage repair plug
US6641617B1 (en) * 1996-02-13 2003-11-04 The General Hospital Corp. Radiation and melt treated ultra high molecular weight polyethylene prosthetic device and method
US20030208278A1 (en) * 2000-09-29 2003-11-06 Robert Richard Supercritical fluid treatment of irradiated polyethylene
US6652586B2 (en) * 2001-07-18 2003-11-25 Smith & Nephew, Inc. Prosthetic devices employing oxidized zirconium and other abrasion resistant surfaces contacting surfaces of cross-linked polyethylene
US20030229155A1 (en) * 2002-06-06 2003-12-11 Howmedica Osteonics Corp. Sequentially cross-linked polyethylene
US20040002770A1 (en) * 2002-06-28 2004-01-01 King Richard S. Polymer-bioceramic composite for orthopaedic applications and method of manufacture thereof
US6676704B1 (en) 1994-08-12 2004-01-13 Diamicron, Inc. Prosthetic joint component having at least one sintered polycrystalline diamond compact articulation surface and substrate surface topographical features in said polycrystalline diamond compact
US6692679B1 (en) * 1998-06-10 2004-02-17 Depuy Orthopaedics, Inc. Cross-linked molded plastic bearings
US6709463B1 (en) 2000-01-30 2004-03-23 Diamicron, Inc. Prosthetic joint component having at least one solid polycrystalline diamond component
US20040065207A1 (en) * 2001-02-22 2004-04-08 Susumu Oishi Beverages containing catechins
US20040111160A1 (en) * 2001-07-18 2004-06-10 Evans David L. Prosthetic devices employing oxidized zirconium and other abrasion resistant surfaces contacting surfaces of cross-linked polyethylene
US20040156879A1 (en) * 2003-01-16 2004-08-12 Muratoglu Orhun K. Methods for making oxidation resistant polymeric material
US6793681B1 (en) 1994-08-12 2004-09-21 Diamicron, Inc. Prosthetic hip joint having a polycrystalline diamond articulation surface and a plurality of substrate layers
US6800670B2 (en) 1996-07-09 2004-10-05 Orthopaedic Hospital Crosslinking of polyethylene for low wear using radiation and thermal treatments
US20040199260A1 (en) * 2000-01-30 2004-10-07 Pope Bill J. Prosthetic joint component having at least one sintered polycrystalline diamond compact articulation surface and substrate surface topographical features in said polycrystalline diamond compact
US20040210316A1 (en) * 2003-04-15 2004-10-21 Richard King Implantable orthopaedic device and method for making the same
US6818172B2 (en) 2000-09-29 2004-11-16 Depuy Products, Inc. Oriented, cross-linked UHMWPE molding for orthopaedic applications
US20040265165A1 (en) * 2003-06-30 2004-12-30 Depuy Products, Inc. Free radical quench process for irradiated ultrahigh molecular weight polyethylene
US20040262809A1 (en) * 2003-06-30 2004-12-30 Smith Todd S. Crosslinked polymeric composite for orthopaedic implants
US20040266903A1 (en) * 2003-06-30 2004-12-30 Depuy Products, Inc. Free radical quench process for irradiated ultrahigh molecular weight polyethylene
US20050008886A1 (en) * 2001-10-10 2005-01-13 Hubert Rosing Method for producing polymer semi-products with high and ultra-high molecular weight, resulting semi-products and uses thereof
US20050070625A1 (en) * 2001-09-13 2005-03-31 Perplas Limited Method of crosslinking polyolefins
EP1520877A1 (en) 2003-09-30 2005-04-06 Depuy Products, Inc. Medical implant or medical implant part with ultrahigh molecular weight polyethylene and at least one hydrophilic polymer
US20050087915A1 (en) * 1999-12-08 2005-04-28 Diamicron, Inc. Carbides as a substrate material in prosthetic joints
US20050110187A1 (en) * 1999-12-08 2005-05-26 Diamicron, Inc. Use of Ti and Nb cemented in TiC in prosthetic joints
US20050133277A1 (en) * 2003-08-28 2005-06-23 Diamicron, Inc. Superhard mill cutters and related methods
US20050165495A1 (en) * 1996-02-13 2005-07-28 The General Hospital Corporation Radiation melt treated ultra high molecular weight polyethylene prosthetic devices
US20050203630A1 (en) * 2000-01-30 2005-09-15 Pope Bill J. Prosthetic knee joint having at least one diamond articulation surface
US20060004168A1 (en) * 2004-06-30 2006-01-05 Keith Greer Low crystalline polymeric material for orthopaedic implants and an associated method
US20060079595A1 (en) * 2004-10-07 2006-04-13 Schroeder David W Solid state deformation processing of crosslinked high molecular weight polymeric materials
US20060079596A1 (en) * 2004-10-07 2006-04-13 Schroeder David W Crosslinked polymeric material with enhanced strength and process for manufacturing
US20060142868A1 (en) * 2004-12-21 2006-06-29 Zimmer Technology, Inc. Selective crosslinking of orthopaedic implants
US20060142449A1 (en) * 2004-12-23 2006-06-29 Depuy Products, Inc. Polymer composition comprising cross-linked polyethylene and methods for making the same
US20060149387A1 (en) * 2004-12-30 2006-07-06 Smith Todd S Orthopaedic bearing and method for making the same
US20060149388A1 (en) * 2004-12-30 2006-07-06 Smith Todd S Orthopaedic bearing and method for making the same
US20060223905A1 (en) * 2005-03-31 2006-10-05 Zimmer Technology, Inc. Liquid bath annealing of polymers for orthopaedic implants
US20060243624A1 (en) * 2003-06-10 2006-11-02 Meadwestvaco Corporation Resin packaging
US20060263233A1 (en) * 1999-12-08 2006-11-23 Diamicron, Inc. Use of a metal and Sn as a solvent material for the bulk crystallization and sintering of diamond to produce biocompatbile biomedical devices
US7186364B2 (en) 2002-01-28 2007-03-06 Depuy Products, Inc. Composite prosthetic bearing constructed of polyethylene and an ethylene-acrylate copolymer and method for making the same
US20070067044A1 (en) * 2005-09-22 2007-03-22 Depuy Products, Inc. Orthopaedic bearing material
US20070077268A1 (en) * 2005-09-30 2007-04-05 Depuy Products, Inc. Hydrophobic carrier modified implants for beneficial agent delivery
US20070232716A1 (en) * 2006-04-04 2007-10-04 Fina Technology, Inc. Cross-linking resins
US20070232761A1 (en) * 2006-03-31 2007-10-04 Depuy Products, Inc. Bearing material of medical implant having reduced wear rate and method for reducing wear rate
WO2007024689A3 (en) * 2005-08-22 2007-11-08 Gen Hospital Corp Dba Massachu Oxidation resistant homogenized polymeric material
US20080033573A1 (en) * 2003-09-19 2008-02-07 Depuy Products, Inc. Medical implant or medical implant part comprising porous uhmwpe and process for producing the same
US20080085982A1 (en) * 2002-01-29 2008-04-10 Paul Smith Sintering Ultrahigh Molecular Weight Polyethylene
US20080090934A1 (en) * 2004-05-11 2008-04-17 The General Hospital Corporation Dba Massachusetts General Hospital Methods for making oxidation resistant polymeric material
US7364685B2 (en) 2001-02-05 2008-04-29 Plus Orthopedics Ag Method for producing implant parts from highly cross-linked UHMWPE and implant parts for human medicine
US20080154380A1 (en) * 2000-01-30 2008-06-26 Dixon Richard H Articulating diamond-surfaced spinal implants
US20080197541A1 (en) * 2005-06-14 2008-08-21 Omni Life Science, Inc Crosslinked Polyethylene Article
JP2009006170A (en) * 1996-02-13 2009-01-15 Massachusetts Inst Of Technol <Mit> Radiation and melt treated ultra high molecular weight polyethylene prosthetic device
US20090030524A1 (en) * 2007-07-27 2009-01-29 Biomet Manufacturing Corp. Antioxidant doping of crosslinked polymers to form non-eluting bearing components
US20090046967A1 (en) * 2001-04-22 2009-02-19 Pope Bill J Bearings, races and components thereof having diamond and other superhard surfaces
US7547405B2 (en) 2004-10-07 2009-06-16 Biomet Manufacturing Corp. Solid state deformation processing of crosslinked high molecular weight polymeric materials
US20090192610A1 (en) * 2008-01-30 2009-07-30 Zimmer, Inc. Orthopedic component of low stiffness
US20090212343A1 (en) * 2005-06-15 2009-08-27 Actel Corporation Non-volatile two-transistor programmable logic cell and array layout
US20090220580A1 (en) * 2005-04-20 2009-09-03 Senju Pharmaceutical Co., Ltd. Percutaneous Absorption Formulation
US20090263643A1 (en) * 2005-04-07 2009-10-22 Gardinier Clayton F Use of sn and pore size control to improve biocompatibility in polycrystalline diamond compacts
US20090288366A1 (en) * 2008-05-23 2009-11-26 Phillip Andrew Schorr Vacuum packaged products and methods for making same
US20090326667A1 (en) * 2008-06-30 2009-12-31 Williams John L Orthopaedic femoral component having controlled condylar curvature
US20090326664A1 (en) * 2008-06-30 2009-12-31 Wagner Christel M Posterior cructiate-retaining orthopaedic knee prosthesis having controlled condylar curvature
US20090326665A1 (en) * 2008-06-30 2009-12-31 Wyss Joseph G Posterior stabilized orthopaedic knee prosthesis having controlled condylar curvature
US20100022678A1 (en) * 2008-07-24 2010-01-28 Zimmer, Inc. Reduction of free radicals in crosslinked polyethylene by infrared heating
US20100025898A1 (en) * 2000-01-30 2010-02-04 Pope Bill J USE OF Ti AND Nb CEMENTED TiC IN PROSTHETIC JOINTS
US20100036491A1 (en) * 2008-08-05 2010-02-11 Howmedica Osteonics Corp. Polyethylene cross-linked with an anthocyanin
US20100036500A1 (en) * 2008-06-30 2010-02-11 Heldreth Mark A Orthopaedic knee prosthesis having controlled condylar curvature
US20100063594A1 (en) * 2007-09-28 2010-03-11 Hazebrouck Stephen A Fixed-bearing knee prosthesis having interchangeable components
US20100069576A1 (en) * 2006-10-30 2010-03-18 Smith & Nephew Orthopaedics Ag Processes comprising crosslinking polyethylene or using crosslinked polyethylene
US7683133B2 (en) 2006-08-25 2010-03-23 Depuy Products, Inc. Bearing material of medical implant and methods for making it
DE102008053793A1 (en) 2008-10-21 2010-04-22 Aesculap Ag Synthetic polymer material, useful for producing medical articles e.g. catheters and trocar, comprises amino acids and/or peptides having anti-oxidative effect
US20100144930A1 (en) * 2007-03-20 2010-06-10 Smith & Nephew Orthopaedics Ag Oxidation resistant highly-crosslinked uhmwpe
US20100190882A1 (en) * 2007-01-25 2010-07-29 The General Hosital Corporation Methods for making oxidation-resistant cross-linked polymeric materials
US20100190920A1 (en) * 2007-02-14 2010-07-29 Anuj Bellare Crosslinked polymers and methods of making the same
US20100198353A1 (en) * 2000-01-30 2010-08-05 Pope Bill J USE OF Ti and Nb CEMENTED IN TiC IN PROSTHETIC JOINTS
US20100331995A1 (en) * 2007-11-06 2010-12-30 Harold Jan Smelt Process for producing high molecular weight polyethylene
US20110028600A1 (en) * 2007-04-10 2011-02-03 Zimmer, Inc. Antioxidant stabilized crosslinked ultra-high molecular weight polyethylene for medical device applications
US7883653B2 (en) 2004-12-30 2011-02-08 Depuy Products, Inc. Method of making an implantable orthopaedic bearing
US20110036748A1 (en) * 2007-10-12 2011-02-17 Peak Plastic & Metal Products Wafer Container With Staggered Wall Structure
US20110112646A1 (en) * 2007-09-04 2011-05-12 Smith & Nephew, Inc. Ultra high molecular weight polyethylene for bearing surfaces
US20110116968A1 (en) * 2008-05-13 2011-05-19 Smith & Nephew Orthopaedics Ag Oxidation resistant highly-crosslinked uhmwpe
US20110135917A1 (en) * 2005-08-18 2011-06-09 Zimmer Gmbh Ultra High Molecular Weight Polyethylene Articles And Methods Of Forming Ultra High Molecular Weight Polyethylene Articles
US20110146348A1 (en) * 2009-06-26 2011-06-23 Harding David P Thick sintered polycrystalline diamond and sintered jewelry
EP2384774A2 (en) 2010-05-07 2011-11-09 Howmedica Osteonics Corp. Surface crosslinked polyethylene
US8206451B2 (en) 2008-06-30 2012-06-26 Depuy Products, Inc. Posterior stabilized orthopaedic prosthesis
US8262976B2 (en) 2004-10-07 2012-09-11 Biomet Manufacturing Corp. Solid state deformation processing of crosslinked high molecular weight polymeric materials
USRE44762E1 (en) 1994-09-21 2014-02-11 Bmg Incorporated Ultra high molecular weight polyethylene molded article for artificial joints and method of preparing the same
US8669299B2 (en) 2007-04-10 2014-03-11 Zimmer, Inc. Antioxidant stabilized crosslinked ultra-high molecular weight polyethylene for medical device applications
US20140262858A1 (en) * 2011-10-21 2014-09-18 Ranbaxy Laboratories Limited Packaging for alitretinoin
US9011547B2 (en) 2010-01-21 2015-04-21 Depuy (Ireland) Knee prosthesis system
US20150128527A1 (en) * 2011-05-09 2015-05-14 Abbott Cardiovascular Systems Inc. Methods of stabilizing molecular weight of polymer stents after sterilization
US9119723B2 (en) 2008-06-30 2015-09-01 Depuy (Ireland) Posterior stabilized orthopaedic prosthesis assembly
EP2921186A1 (en) 2014-03-21 2015-09-23 Howmedica Osteonics Corp. Annealing method for cross-linked polyethylene
US9168145B2 (en) 2008-06-30 2015-10-27 Depuy (Ireland) Posterior stabilized orthopaedic knee prosthesis having controlled condylar curvature
US9204967B2 (en) 2007-09-28 2015-12-08 Depuy (Ireland) Fixed-bearing knee prosthesis having interchangeable components
US9382023B2 (en) 2010-01-22 2016-07-05 Allegiance Corporation Methods for packaging and sterilizing elastomeric articles, and packaged elastomeric articles produced thereby
US9398956B2 (en) 2007-09-25 2016-07-26 Depuy (Ireland) Fixed-bearing knee prosthesis having interchangeable components
US9492280B2 (en) 2000-11-28 2016-11-15 Medidea, Llc Multiple-cam, posterior-stabilized knee prosthesis
US9586370B2 (en) 2013-08-15 2017-03-07 Biomet Manufacturing, Llc Method for making ultra high molecular weight polyethylene
US9708467B2 (en) 2013-10-01 2017-07-18 Zimmer, Inc. Polymer compositions comprising one or more protected antioxidants
US10184031B2 (en) 2014-03-12 2019-01-22 Zimmer, Inc. Melt-stabilized ultra high molecular weight polyethylene and method of making the same
US10265891B2 (en) 2014-12-03 2019-04-23 Zimmer, Inc. Antioxidant-infused ultra high molecular weight polyethylene
US11952439B2 (en) 2020-06-25 2024-04-09 b-ONE Medical (Suzhou) Co., Ltd. Surface gradient cross-linking method of ultra-high molecular weight polyethylene and the application thereof

Families Citing this family (75)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5505984A (en) * 1993-01-21 1996-04-09 England; Garry L. Method for forming biocompatible components using an isostatic press
US5830396A (en) * 1993-01-21 1998-11-03 Biomet, Inc. Method for processing thermoplastics, thermosets and elastomers
US5414049A (en) * 1993-06-01 1995-05-09 Howmedica Inc. Non-oxidizing polymeric medical implant
US5577368A (en) * 1995-04-03 1996-11-26 Johnson & Johnson Professional, Inc. Method for improving wear resistance of polymeric bioimplantable components
IT1298376B1 (en) * 1997-12-16 2000-01-05 Samo Spa CROSS-LINKING AND STERILIZATION TREATMENT FOR THE PRODUCTION OF POLYETHYLENE PRODUCTS WITH HIGH TRIBOLOGICAL CHARACTERISTICS,
DE69922435T2 (en) * 1998-06-10 2005-12-08 Depuy Products, Inc., Warsaw Method for producing crosslinked, molded plastic bearings
EP1413414B1 (en) * 1998-06-10 2006-12-13 Depuy Products, Inc. Method for forming cross-linked molded plastic bearings
EP0995450B1 (en) * 1998-10-21 2002-06-26 Sulzer Orthopädie AG UHMW-polyethylene for implants
EP0995449A1 (en) 1998-10-21 2000-04-26 Sulzer Orthopädie AG UHMW-polyethylene for implants
US6986868B2 (en) * 1998-11-20 2006-01-17 Coloplast A/S Method for sterilizing a medical device having a hydrophilic coating
CA2349198C (en) * 1998-11-20 2010-10-19 Coloplast A/S A method for sterilizing a medical device having a hydrophilic coating
CA2355930C (en) * 1999-01-22 2011-01-04 Multigig Limited Electronic circuitry
US6203844B1 (en) 1999-04-01 2001-03-20 Joon B. Park Precoated polymeric prosthesis and process for making same
US6239197B1 (en) * 1999-04-23 2001-05-29 Great Lakes Chemical Corporation Vacuum de-aerated powdered polymer additives
AU4890400A (en) * 1999-07-29 2001-02-01 Depuy Orthopaedics, Inc. Two step gamma irradiation of polymeric bioimplant
US6794423B1 (en) * 1999-07-30 2004-09-21 Stephen Li Fracture-resistant, cross-linked ultra high molecular weight polyethylene shaped material and articles made therefrom
US6579532B1 (en) * 2000-09-08 2003-06-17 Ferro Corporation Orthopedic mixtures prepared by supercritical fluid processing techniques
JP3757264B2 (en) * 2001-03-27 2006-03-22 独立行政法人産業技術総合研究所 Silsesquioxane-based polymer molded body and method for producing the same
US7776085B2 (en) 2001-05-01 2010-08-17 Amedica Corporation Knee prosthesis with ceramic tibial component
ATE419810T1 (en) * 2001-05-01 2009-01-15 Amedica Corp RADIO-LUCENT BONE TRANSPLANT
US7695521B2 (en) 2001-05-01 2010-04-13 Amedica Corporation Hip prosthesis with monoblock ceramic acetabular cup
AU2002324443A1 (en) 2001-06-14 2003-01-02 Amedica Corporation Metal-ceramic composite articulation
US7150853B2 (en) * 2001-11-01 2006-12-19 Advanced Cardiovascular Systems, Inc. Method of sterilizing a medical device
DE10160329A1 (en) * 2001-12-07 2003-06-18 Merck Patent Gmbh Polymer-based material containing silica particles
EP1332733B1 (en) 2002-01-28 2006-06-14 Depuy Products, Inc. Composite prosthetic bearing and method of manufacture
EP1369094B1 (en) 2002-05-31 2014-11-26 Zimmer GmbH Implant and method of manufacturing a sterile packaged implant
US7364678B2 (en) * 2002-12-10 2008-04-29 Dsm Ip Assets B.V. Process for making and process for converting polyolefin fibres
WO2004058098A2 (en) 2002-12-17 2004-07-15 Amedica Corporation Total disc implant
EP1624906A1 (en) * 2003-05-19 2006-02-15 Tjaart Andries Du Plessis Preparation of an osteoinductive agent
US6996952B2 (en) * 2003-09-30 2006-02-14 Codman & Shurtleff, Inc. Method for improving stability and effectivity of a drug-device combination product
GB2429164B (en) * 2004-03-11 2008-12-24 Acumed Llc Systems for bone replacement
US20060280645A1 (en) * 2005-06-02 2006-12-14 Scott Sellers Method for terminal sterilization of transdermal delivery devices
AU2006252342A1 (en) * 2005-06-02 2006-12-07 Alza Corporation Method for terminal sterilization of transdermal delivery devices
US8252058B2 (en) 2006-02-16 2012-08-28 Amedica Corporation Spinal implant with elliptical articulatory interface
US20070209957A1 (en) * 2006-03-09 2007-09-13 Sdgi Holdings, Inc. Packaging system for medical devices
US20080036111A1 (en) * 2006-08-09 2008-02-14 Dehchuan Sun Non-oxidizing thermally crosslinked polymeric material and medical implant
EP2059493B1 (en) * 2006-09-01 2016-11-16 Basf Se Recovery of phenol ligands during the production of isopulegol
US8562616B2 (en) 2007-10-10 2013-10-22 Biomet Manufacturing, Llc Knee joint prosthesis system and method for implantation
US8157869B2 (en) 2007-01-10 2012-04-17 Biomet Manufacturing Corp. Knee joint prosthesis system and method for implantation
US8163028B2 (en) 2007-01-10 2012-04-24 Biomet Manufacturing Corp. Knee joint prosthesis system and method for implantation
US8187280B2 (en) 2007-10-10 2012-05-29 Biomet Manufacturing Corp. Knee joint prosthesis system and method for implantation
US8328873B2 (en) 2007-01-10 2012-12-11 Biomet Manufacturing Corp. Knee joint prosthesis system and method for implantation
ES2351779T3 (en) * 2007-03-27 2011-02-10 Dsm Ip Assets B.V. PROCESS FOR THE ELIMINATION OF THE RESIDUAL SOLVENT OF THREAD OF A FILAMENT SPINED IN GEL, THE FILAMENT, MULTI-FILAMENT THREAD AND PRODUCTS THAT INCLUDE THE FILAMENT.
US20110035017A1 (en) * 2007-09-25 2011-02-10 Depuy Products, Inc. Prosthesis with cut-off pegs and surgical method
US20110035018A1 (en) * 2007-09-25 2011-02-10 Depuy Products, Inc. Prosthesis with composite component
US8715359B2 (en) 2009-10-30 2014-05-06 Depuy (Ireland) Prosthesis for cemented fixation and method for making the prosthesis
US9095324B2 (en) * 2008-06-20 2015-08-04 Boston Scientific Scimed, Inc. Package assembly
US20100022677A1 (en) * 2008-07-24 2010-01-28 Zimmer, Inc. Reduction of free radicals in crosslinked polyethylene by infrared heating
US8765040B2 (en) * 2008-08-11 2014-07-01 Abbott Cardiovascular Systems Inc. Medical device fabrication process including strain induced crystallization with enhanced crystallization
WO2010057644A1 (en) 2008-11-20 2010-05-27 Zimmer Gmbh Polyethylene materials
US9101476B2 (en) 2009-05-21 2015-08-11 Depuy (Ireland) Prosthesis with surfaces having different textures and method of making the prosthesis
US11213397B2 (en) 2009-05-21 2022-01-04 Depuy Ireland Unlimited Company Prosthesis with surfaces having different textures and method of making the prosthesis
DK2617392T3 (en) 2009-10-30 2015-02-16 Depuy Synthes Products Llc Prosthesis with surfaces with different textures
EP2316384B1 (en) 2009-10-30 2013-04-03 DePuy Products, Inc. Prosthesis with modular extensions
EP2319460A1 (en) 2009-10-30 2011-05-11 DePuy Products, Inc. Prosthesis with cut-off pegs
EP2319462B1 (en) 2009-10-30 2013-04-03 DePuy Products, Inc. Prosthesis with composite component
ES2459718T3 (en) 2009-10-30 2014-05-12 Depuy (Ireland) Cementless fixation prosthesis
US8613880B2 (en) 2010-04-21 2013-12-24 Abbott Cardiovascular Systems Inc. Post electron beam conditioning of polymeric medical devices
US8715569B2 (en) * 2010-08-20 2014-05-06 Abbott Cardiovascular Systems Inc. Post electron beam stabilization of polymeric medical devices
US8399535B2 (en) 2010-06-10 2013-03-19 Zimmer, Inc. Polymer [[s]] compositions including an antioxidant
US8235209B2 (en) 2010-08-11 2012-08-07 Boston Scientific Scimed, Inc. Medical device packaging and methods for preparing and packaging medical devices
US8973748B2 (en) 2011-01-19 2015-03-10 Boston Scientific Scime, Inc. Medical device packaging and methods for preparing and packaging medical devices
US9096368B2 (en) 2011-01-19 2015-08-04 Boston Scientific Scimed, Inc. Medical device packaging and methods for preparing and packaging medical devices
US8556970B2 (en) * 2011-09-28 2013-10-15 Depuy Mitek, Llc Graft introducer
DE102012010155B4 (en) 2012-05-24 2015-06-11 Pan-Biotech Gmbh Cell culture container for single use
GB2524668A (en) 2012-09-10 2015-09-30 Acumed Llc Radial head prosthesis with floating articular member
EP3143988A1 (en) 2013-03-14 2017-03-22 Fresenius Kabi Deutschland GmbH Injectable morphine formulations
AU2014230836C1 (en) 2013-03-14 2018-12-20 Fresenius Kabi Deutschland Gmbh Packaging system for oxygen-sensitive drugs
US9237953B2 (en) 2013-03-15 2016-01-19 Depuy (Ireland) Mechanical assembly of pegs to prosthesis
US20160279055A1 (en) 2013-07-22 2016-09-29 Imprimis Pharmaceuticals, Inc. Pharmaceutical ophthalmic compositions for intraocular administration and methods for fabricating thereof
US9144499B2 (en) 2013-12-17 2015-09-29 Depuy (Ireland) Low profile mobile/fixed prosthetic knee systems
US9763792B2 (en) 2015-10-01 2017-09-19 Acumed Llc Radial head prosthesis with rotate-to-lock interface
US10070959B2 (en) 2016-09-28 2018-09-11 DePuy Synthes Products, Inc. Method of texturing prosthetic implants
WO2021154204A1 (en) 2020-01-27 2021-08-05 Formosa Plastics Corporation, U.S.A. Process for preparing catalysts and catalyst compositions
WO2023239560A1 (en) 2022-06-09 2023-12-14 Formosa Plastics Corporaton, U.S.A. Clay composite support-activators and catalyst compositions

Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3297641A (en) * 1964-01-17 1967-01-10 Grace W R & Co Process for cross-linking polyethylene
US3352818A (en) * 1964-01-31 1967-11-14 Glanzstoff Ag Stability of polyolefines
US3758273A (en) * 1970-04-03 1973-09-11 Gillette Co Processes for sterilizing polypropylene objects
GB2180815A (en) * 1985-09-27 1987-04-08 Nissho Kk Radiation-sterilized, packaged medical device
US5037928A (en) * 1989-10-24 1991-08-06 E. I. Du Pont De Nemours And Company Process of manufacturing ultrahigh molecular weight linear polyethylene shaped articles
EP0177552B1 (en) * 1984-03-06 1992-05-27 ZACHARIADES, Anagnostis E. The preparation of ultra high molecular weight polyethylene morphologies of totally fused particles with superior mechanical performance
US5153039A (en) * 1990-03-20 1992-10-06 Paxon Polymer Company, L.P. High density polyethylene article with oxygen barrier properties
US5160464A (en) * 1983-12-09 1992-11-03 National Research Development Corporation Polymer irradiation

Family Cites Families (62)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE544324A (en) 1955-01-11
US2904480A (en) 1955-06-06 1959-09-15 Grace W R & Co Polyethylene
US3563869A (en) * 1957-11-05 1971-02-16 Grace W R & Co Irradiated polyethylene
US3022543A (en) 1958-02-07 1962-02-27 Grace W R & Co Method of producing film having improved shrink energy
US3057791A (en) 1959-07-06 1962-10-09 Phillips Petroleum Co Radiation curing of polymers
US3090770A (en) 1960-04-26 1963-05-21 Grace W R & Co Blended polyethylene compositions of improved clarity and method of making same
US3162623A (en) 1961-12-26 1964-12-22 Du Pont Crosslinking of polymers with nitrogen fluorides
US3362897A (en) * 1962-11-21 1968-01-09 Gen Electric Stable irradiated polyethylene
DE1669649B2 (en) 1966-05-27 1971-05-19 Badische Anilin- & Soda-Fabrik Ag, 6700 Ludwigshafen PROCESS FOR MANUFACTURING FINE PARTICLE, FOAM-SHAPED OLEFINE POLYMERIZATES WITH HIGH HEAT STABILITY
US3832827A (en) * 1967-12-18 1974-09-03 J Lemelson Container forming and filling apparatus
GB1324919A (en) * 1970-11-13 1973-07-25 Atomic Energy Commission Preparation of filled polyethylenes
JPS526314B2 (en) 1971-11-01 1977-02-21
AU523866B2 (en) 1978-04-18 1982-08-19 Du Pont Canada Inc. Manufacture of film
US4241463A (en) 1978-10-16 1980-12-30 Precision Cast Specialties, Inc. Prosthetic implant device
GB2060469B (en) * 1979-06-06 1983-09-28 Nat Res Dev Drawing thermoplastics material
US5017627A (en) 1980-10-09 1991-05-21 National Research Development Corporation Composite material for use in orthopaedics
US4586995A (en) * 1982-09-17 1986-05-06 Phillips Petroleum Company Polymer and irradiation treatment method
JPS5971830A (en) 1982-10-18 1984-04-23 Nippon Sheet Glass Co Ltd Manufacture of lens of refractive index distribution type
EP0157601B1 (en) * 1984-03-30 1991-05-08 National Research Development Corporation Tubular materials
ATE54094T1 (en) * 1984-04-13 1990-07-15 Nat Res Dev PROCESSES FOR DEFORMING IN THE SOLID STATE.
US4655769A (en) * 1984-10-24 1987-04-07 Zachariades Anagnostis E Ultra-high-molecular-weight polyethylene products including vascular prosthesis devices and methods relating thereto and employing pseudo-gel states
US4820466A (en) * 1985-01-31 1989-04-11 Zachariades Anagnostis E Process for obtaining ultra-high modulus products
US4950151A (en) * 1985-01-31 1990-08-21 Zachariades Anagnostic E Rolling die for producing high modulus products
ZA86528B (en) 1985-01-31 1986-09-24 Himont Inc Polypropylene with free-end long chain branching,process for making it,and use thereof
DE3545116A1 (en) 1985-05-17 1986-11-20 Transaktor KB International, Göteborg BOTTLE FOR WATER EMERGENCY CATERING AND METHOD FOR PRODUCING A BOTTLE WITH WATER EMERGENCY CATERING
US4701288A (en) * 1985-06-05 1987-10-20 Bausch & Lomb Incorporated Method of making articles of dissimilar polymer compositions
US4965846A (en) * 1986-08-11 1990-10-23 Baxter International Inc. Pivot pin bearing/seal with loose eyelet especially suited for disposable continuous flow blood filtration system cartridges
GB2207436B (en) * 1987-07-24 1991-07-24 Nat Research And Dev Corp The Solid phase deformation process
US5047446A (en) 1988-07-22 1991-09-10 Himont Incorporated Thermal treatment of irradiated propylene polymer material
GB8827967D0 (en) * 1988-11-30 1989-01-05 Ward I M Die-free drawing
EP0446300B1 (en) * 1988-12-02 1996-06-05 E.I. Du Pont De Nemours And Company Ultrahigh molecular weight linear polyethylene, articles and processes of manufacture
ES2073012T3 (en) * 1988-12-02 1995-08-01 Du Pont PROCEDURE FOR THE MANUFACTURE OF CONFIGURED ARTICLES IN LINEAR POLYETHYLENE OF ULTRAELEVATED MOLECULAR WEIGHT.
US5030402A (en) * 1989-03-17 1991-07-09 Zachariades Anagnostis E Process for producing a new class of ultra-high-molecular-weight polyethylene orthopaedic prostheses with enhanced mechanical properties
US5160677A (en) * 1989-12-15 1992-11-03 United States Surgical Corporation Pressurized powder support for treating processes
CA2031406C (en) 1989-12-21 2002-05-28 Paolo Galli Graft copolymers of polyolefins and a method of producing same
US5200439A (en) * 1990-04-13 1993-04-06 Mitsui Toatsu Chemicals, Inc. Method for increasing intrinsic viscosity of syndiotactic polypropylene
NL9001745A (en) * 1990-08-01 1992-03-02 Stamicarbon SOLUTION OF ULTRA-HIGH MOLECULAR POLYETHENE.
US5352732A (en) * 1990-08-07 1994-10-04 E. I. Du Pont De Nemours And Company Homogeneous, high modulus ultrahigh molecular weight polyethylene composites and processes for the preparation thereof
US5292584A (en) 1991-04-11 1994-03-08 E. I. Du Pont De Nemours And Company Ultrahigh molecular weight polyethylene and lightly-filled composites thereof
US5508319A (en) 1991-06-21 1996-04-16 Montell North America Inc. High melt strength, ethylene polymer, process for making it, and use thereof
US5505984A (en) * 1993-01-21 1996-04-09 England; Garry L. Method for forming biocompatible components using an isostatic press
US5414049A (en) * 1993-06-01 1995-05-09 Howmedica Inc. Non-oxidizing polymeric medical implant
WO1995006148A1 (en) 1993-08-20 1995-03-02 Smith & Nephew Richards, Inc. Self-reinforced ultra-high molecular weight polyethylene composites
WO1996009330A1 (en) 1994-09-21 1996-03-28 Bmg Incorporated Ultrahigh-molecular-weight polyethylene molding for artificial joint and process for producing the molding
CA2166450C (en) * 1995-01-20 2008-03-25 Ronald Salovey Chemically crosslinked ultrahigh molecular weight polyethylene for artificial human joints
US5609643A (en) 1995-03-13 1997-03-11 Johnson & Johnson Professional, Inc. Knee joint prosthesis
US5577368A (en) 1995-04-03 1996-11-26 Johnson & Johnson Professional, Inc. Method for improving wear resistance of polymeric bioimplantable components
NZ331107A (en) * 1996-02-13 2000-04-28 Gen Hospital Corp Radiation and melt treated ultra high molecular weight polyethylene prosthetic devices
US5879400A (en) * 1996-02-13 1999-03-09 Massachusetts Institute Of Technology Melt-irradiated ultra high molecular weight polyethylene prosthetic devices
US5753182A (en) * 1996-02-14 1998-05-19 Biomet, Inc. Method for reducing the number of free radicals present in ultrahigh molecular weight polyethylene orthopedic components
US6228900B1 (en) * 1996-07-09 2001-05-08 The Orthopaedic Hospital And University Of Southern California Crosslinking of polyethylene for low wear using radiation and thermal treatments
US6017975A (en) * 1996-10-02 2000-01-25 Saum; Kenneth Ashley Process for medical implant of cross-linked ultrahigh molecular weight polyethylene having improved balance of wear properties and oxidation resistance
EP1028760B1 (en) * 1996-10-15 2004-04-14 Orthopaedic Hospital Wear resistant surface-gradient cross-linked polyethylene
US5874123A (en) * 1997-01-24 1999-02-23 Park; Joon B. Precoated polymeric prosthesis and process for making same
US6432349B1 (en) * 1999-06-29 2002-08-13 Zimmer, Inc. Process of making an articulating bearing surface
US6184265B1 (en) * 1999-07-29 2001-02-06 Depuy Orthopaedics, Inc. Low temperature pressure stabilization of implant component
US6143232A (en) * 1999-07-29 2000-11-07 Bristol-Meyers Squibb Company Method of manufacturing an articulating bearing surface for an orthopaedic implant
JP4400970B2 (en) * 1999-11-22 2010-01-20 若井産業株式会社 Nut packaging method and package
AU2001229421A1 (en) * 2000-01-13 2001-07-24 Orbidex, Inc. System and method of searching and gathering information on-line and off-line
US6395799B1 (en) * 2000-02-21 2002-05-28 Smith & Nephew, Inc. Electromagnetic and mechanical wave energy treatments of UHMWPE
US6503439B1 (en) * 2000-06-15 2003-01-07 Albert H. Burstein Process for forming shaped articles of ultra high molecular weight polyethylene suitable for use as a prosthetic device or a component thereof
US6547828B2 (en) * 2001-02-23 2003-04-15 Smith & Nephew, Inc. Cross-linked ultra-high molecular weight polyethylene for medical implant use

Patent Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3297641A (en) * 1964-01-17 1967-01-10 Grace W R & Co Process for cross-linking polyethylene
US3352818A (en) * 1964-01-31 1967-11-14 Glanzstoff Ag Stability of polyolefines
US3758273A (en) * 1970-04-03 1973-09-11 Gillette Co Processes for sterilizing polypropylene objects
US5160464A (en) * 1983-12-09 1992-11-03 National Research Development Corporation Polymer irradiation
EP0177552B1 (en) * 1984-03-06 1992-05-27 ZACHARIADES, Anagnostis E. The preparation of ultra high molecular weight polyethylene morphologies of totally fused particles with superior mechanical performance
GB2180815A (en) * 1985-09-27 1987-04-08 Nissho Kk Radiation-sterilized, packaged medical device
US5037928A (en) * 1989-10-24 1991-08-06 E. I. Du Pont De Nemours And Company Process of manufacturing ultrahigh molecular weight linear polyethylene shaped articles
US5153039A (en) * 1990-03-20 1992-10-06 Paxon Polymer Company, L.P. High density polyethylene article with oxygen barrier properties

Non-Patent Citations (8)

* Cited by examiner, † Cited by third party
Title
"Combined Chemical and Mechanical Effects on Free Radicals in UHMWPE Joints During Implantation", Journal of Biomedical-Materials Research, vol. 25, pp. 1005-1017, 1991.
"Polypropylene Degradation by 2-Irradiation in Air" American Chemical Society, 1985, pp. 359-371.
"Radiation Effects on Polymers" American Chemical Society, 1991 (from symposium of Aug. 26-31, 1990) pp. 89-92.
"Radical Migration as an Elementary Process in Degradation" in Pure & Applied Chem., vol. 55, No. 10, pp. 1595-1601, 1983.
Combined Chemical and Mechanical Effects on Free Radicals in UHMWPE Joints During Implantation , Journal of Biomedical Materials Research, vol. 25, pp. 1005 1017, 1991. *
Polypropylene Degradation by 2 Irradiation in Air American Chemical Society, 1985, pp. 359 371. *
Radiation Effects on Polymers American Chemical Society, 1991 (from symposium of Aug. 26 31, 1990) pp. 89 92. *
Radical Migration as an Elementary Process in Degradation in Pure & Applied Chem., vol. 55, No. 10, pp. 1595 1601, 1983. *

Cited By (366)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6800095B1 (en) 1994-08-12 2004-10-05 Diamicron, Inc. Diamond-surfaced femoral head for use in a prosthetic joint
US6676704B1 (en) 1994-08-12 2004-01-13 Diamicron, Inc. Prosthetic joint component having at least one sintered polycrystalline diamond compact articulation surface and substrate surface topographical features in said polycrystalline diamond compact
US6793681B1 (en) 1994-08-12 2004-09-21 Diamicron, Inc. Prosthetic hip joint having a polycrystalline diamond articulation surface and a plurality of substrate layers
USRE44762E1 (en) 1994-09-21 2014-02-11 Bmg Incorporated Ultra high molecular weight polyethylene molded article for artificial joints and method of preparing the same
US5611310A (en) * 1995-01-18 1997-03-18 Honda Giken Kogyo Kabushiki Kaisha Driving force-calculating system and control system incorporating same for automotive vehicles
US6281264B1 (en) 1995-01-20 2001-08-28 The Orthopaedic Hospital Chemically crosslinked ultrahigh molecular weight polyethylene for artificial human joints
US20040208841A1 (en) * 1995-01-20 2004-10-21 Ronald Salovey Chemically crosslinked ultrahigh molecular weight polyethylene for artificial human joints
US20030158287A1 (en) * 1995-01-20 2003-08-21 Ronald Salovey Chemically crosslinked ultrahigh molecular weight polyethylene for artificial human joints
US20080133018A1 (en) * 1995-01-20 2008-06-05 Ronald Salovey Chemically crosslinked ultrahigh molecular weight polyethylene for artificial human joints
US20030045603A1 (en) * 1995-01-20 2003-03-06 The Orthopaedic Hospital And University Of Southern California Chemically crosslinked ultrahigh molecular weight polyethylene for artificial human joints
US20010049401A1 (en) * 1995-01-20 2001-12-06 The Orthopaedic Hospital And University Of Southern California Chemically crosslinked ultrahigh molecular weight polyethylene for artificial human joints
US5674290A (en) * 1995-04-05 1997-10-07 Li; Shu-Tung Water-stabilized biopolymeric implants
US5800542A (en) * 1995-04-05 1998-09-01 Li; Shu-Tung Sterilization by gamma irradiation
US20020007219A1 (en) * 1996-02-13 2002-01-17 Merrill Edward W. Radiation and melt treated ultra high molecular weight polyethylene prosthetic devices
US20030105182A1 (en) * 1996-02-13 2003-06-05 Merrill Edward W. Radiation and melt treated ultra high molecular weight polyethylene prosthetic devices
US6641617B1 (en) * 1996-02-13 2003-11-04 The General Hospital Corp. Radiation and melt treated ultra high molecular weight polyethylene prosthetic device and method
US7858671B2 (en) 1996-02-13 2010-12-28 The General Hospital Corporation Radiation and melt treated ultra high molecular weight polyethylene prosthetic devices
US20050010288A1 (en) * 1996-02-13 2005-01-13 Merrill Edward W. Radiation and melt treated ultra high molecular weight polyethylene prosthetic devices
US20090105364A1 (en) * 1996-02-13 2009-04-23 The General Hospital Corporation Radiation and melt treated ultra high molecular weight polyethylene prosthetic devices
US20050006821A1 (en) * 1996-02-13 2005-01-13 The General Hospital Corporation Radiation and melt treated ultra high molecular weight polyethylene prosthetic devices
JP2009006170A (en) * 1996-02-13 2009-01-15 Massachusetts Inst Of Technol <Mit> Radiation and melt treated ultra high molecular weight polyethylene prosthetic device
US8563623B2 (en) 1996-02-13 2013-10-22 The General Hospital Corporation Radiation melt treated ultra high molecular weight polyethylene prosthetic devices
EP1563857A3 (en) * 1996-02-13 2008-06-04 Massachusetts Institute Of Technology Radiation and melt treated ultra high molecular weight polyethylene prosthetic devices
US20030119935A1 (en) * 1996-02-13 2003-06-26 Merrill Edward W. Radiation and melt treated ultra high molecular weight polyethylene prosthetic devices
US20050165495A1 (en) * 1996-02-13 2005-07-28 The General Hospital Corporation Radiation melt treated ultra high molecular weight polyethylene prosthetic devices
US8263676B2 (en) 1996-02-13 2012-09-11 The General Hospital Corporation Radiation and melt treated ultra high molecular weight polyethylene prosthetic devices
US20050056971A1 (en) * 1996-02-13 2005-03-17 Merrill Edward W. Radiation and melt treated ultra high molecular weight polyethylene prosthetic devices
US20050096749A1 (en) * 1996-02-13 2005-05-05 The General Hospital Corporation Radiation and melt treated ultra high molecular weight polyethylene prosthetic devices
US20040132856A1 (en) * 1996-02-13 2004-07-08 Merrill Edward W. Radiation and melt treated ultra high molecular weight polyethylene prosthetic devices
US5879400A (en) * 1996-02-13 1999-03-09 Massachusetts Institute Of Technology Melt-irradiated ultra high molecular weight polyethylene prosthetic devices
US20050267594A1 (en) * 1996-02-13 2005-12-01 The General Hospital Corporation Radiation and melt treated ultra high molecular weight polyethylene prosthetic devices
US8865788B2 (en) 1996-02-13 2014-10-21 The General Hospital Corporation Radiation and melt treated ultra high molecular weight polyethylene prosthetic devices
US6786933B2 (en) 1996-02-13 2004-09-07 The General Hospital Corporation Radiation and melt treated ultra high molecular weight polyethylene prosthetic devices
US6464926B1 (en) 1996-02-13 2002-10-15 The General Hospital Corporation Process of making ultra high molecular weight polyethylene prosthetic devices
US20020156536A1 (en) * 1996-02-13 2002-10-24 Harris William H. Polyethylene hip joint prosthesis with extended range of motion
US5753182A (en) * 1996-02-14 1998-05-19 Biomet, Inc. Method for reducing the number of free radicals present in ultrahigh molecular weight polyethylene orthopedic components
WO1997029787A1 (en) * 1996-02-14 1997-08-21 Biomet, Inc. Method for reducing the number of free radicals present in ultrahigh molecular weight polyethylene orthopedic components
US20050048096A1 (en) * 1996-07-09 2005-03-03 Fu-Wen Shen Crosslinking of polyethylene for low wear using radiation and thermal treatments
US20070100017A1 (en) * 1996-07-09 2007-05-03 Fu-Wen Shen Crosslinking of polyethylene for low wear using radiation and thermal treatments
US8003709B2 (en) 1996-07-09 2011-08-23 Orthopaedic Hospital Crosslinking of polyethylene for low wear using radiation and thermal treatments
US8008365B2 (en) 1996-07-09 2011-08-30 Orthopaedic Hospital Crosslinking of polyethylene for low wear using radiation and thermal treatments
US6800670B2 (en) 1996-07-09 2004-10-05 Orthopaedic Hospital Crosslinking of polyethylene for low wear using radiation and thermal treatments
US6228900B1 (en) 1996-07-09 2001-05-08 The Orthopaedic Hospital And University Of Southern California Crosslinking of polyethylene for low wear using radiation and thermal treatments
US20040266902A1 (en) * 1996-07-09 2004-12-30 Fu-Wen Shen Crosslinking of polyethylene for low wear using radiation and thermal treatments
US20080133021A1 (en) * 1996-07-09 2008-06-05 Fu-Wen Shen Crosslinking of polyethylene for low wear using radiation and thermal treatments
US6562540B2 (en) 1996-10-02 2003-05-13 Depuy Orthopaedics, Inc. Process for medical implant of cross-linked ultrahigh molecular weight polyethylene having improved balance of wear properties and oxidation resistance
US6017975A (en) * 1996-10-02 2000-01-25 Saum; Kenneth Ashley Process for medical implant of cross-linked ultrahigh molecular weight polyethylene having improved balance of wear properties and oxidation resistance
US6494917B1 (en) 1996-10-15 2002-12-17 Orthopaedic Hospital Wear resistant surface-gradient crosslinked polyethylene
US6165220A (en) * 1996-10-15 2000-12-26 The Orthopaedic Hospital Wear resistant surface-gradient crosslinked polyethylene
WO1998016258A1 (en) * 1996-10-15 1998-04-23 The Orthopaedic Hospital Wear resistant surface-gradient cross-linked polyethylene
US6692679B1 (en) * 1998-06-10 2004-02-17 Depuy Orthopaedics, Inc. Cross-linked molded plastic bearings
WO2000011980A1 (en) * 1998-08-27 2000-03-09 Gardon John L Non-allergenic medical and health care devices made from crosslinked synthetic elastomers
US6355215B1 (en) 1999-03-10 2002-03-12 Implex Corp. Wear-resistant olefinic medical implant and thermal treatment container therefor
US6849224B2 (en) 1999-04-21 2005-02-01 Howmedica Osteonics Corp. Methods for preparing selectively cross-linked polyethylene orthopedic devices
WO2000062717A1 (en) 1999-04-21 2000-10-26 Howmedica Osteonics Corp. Selectively cross-linked polyethylene orthopedic devices
US20050113935A1 (en) * 1999-04-21 2005-05-26 Howmedica Osteonics Corp. Selectively cross-linked polyethylene orthopedic devices
US6627141B2 (en) 1999-06-08 2003-09-30 Depuy Orthopaedics, Inc. Method for molding a cross-linked preform
US6245276B1 (en) 1999-06-08 2001-06-12 Depuy Orthopaedics, Inc. Method for molding a cross-linked preform
WO2002006031A1 (en) 1999-06-08 2002-01-24 Depuy Orthopaedics, Inc. Method for compression molding a cross-linked preform
US6432349B1 (en) 1999-06-29 2002-08-13 Zimmer, Inc. Process of making an articulating bearing surface
US6143232A (en) * 1999-07-29 2000-11-07 Bristol-Meyers Squibb Company Method of manufacturing an articulating bearing surface for an orthopaedic implant
EP1072276A1 (en) * 1999-07-29 2001-01-31 Depuy Orthopaedics, Inc. Low temperature pressure stabilisation of implant component
EP1072277A1 (en) * 1999-07-29 2001-01-31 Depuy Orthopaedics, Inc. Gamma irradiated heat treated implant for mechanical strength
US6184265B1 (en) 1999-07-29 2001-02-06 Depuy Orthopaedics, Inc. Low temperature pressure stabilization of implant component
US6365089B1 (en) 1999-09-24 2002-04-02 Zimmer, Inc. Method for crosslinking UHMWPE in an orthopaedic implant
US20050110187A1 (en) * 1999-12-08 2005-05-26 Diamicron, Inc. Use of Ti and Nb cemented in TiC in prosthetic joints
US20060263233A1 (en) * 1999-12-08 2006-11-23 Diamicron, Inc. Use of a metal and Sn as a solvent material for the bulk crystallization and sintering of diamond to produce biocompatbile biomedical devices
US7678325B2 (en) 1999-12-08 2010-03-16 Diamicron, Inc. Use of a metal and Sn as a solvent material for the bulk crystallization and sintering of diamond to produce biocompatbile biomedical devices
US20050087915A1 (en) * 1999-12-08 2005-04-28 Diamicron, Inc. Carbides as a substrate material in prosthetic joints
US7556763B2 (en) 1999-12-08 2009-07-07 Diamicron, Inc. Method of making components for prosthetic joints
US7569176B2 (en) 1999-12-08 2009-08-04 Diamicron, Inc. Method for making a sintered superhard prosthetic joint component
US6517583B1 (en) 2000-01-30 2003-02-11 Diamicron, Inc. Prosthetic hip joint having a polycrystalline diamond compact articulation surface and a counter bearing surface
US20080154380A1 (en) * 2000-01-30 2008-06-26 Dixon Richard H Articulating diamond-surfaced spinal implants
US20100025898A1 (en) * 2000-01-30 2010-02-04 Pope Bill J USE OF Ti AND Nb CEMENTED TiC IN PROSTHETIC JOINTS
US8016889B2 (en) 2000-01-30 2011-09-13 Diamicron, Inc Articulating diamond-surfaced spinal implants
US6494918B1 (en) 2000-01-30 2002-12-17 Diamicron, Inc. Component for a prosthetic joint having a diamond load bearing and articulation surface
US20050203630A1 (en) * 2000-01-30 2005-09-15 Pope Bill J. Prosthetic knee joint having at least one diamond articulation surface
US8603181B2 (en) 2000-01-30 2013-12-10 Dimicron, Inc Use of Ti and Nb cemented in TiC in prosthetic joints
US6425922B1 (en) 2000-01-30 2002-07-30 Diamicron, Inc. Prosthetic hip joint having at least one sintered polycrystalline diamond compact articulation surface
US20040199260A1 (en) * 2000-01-30 2004-10-07 Pope Bill J. Prosthetic joint component having at least one sintered polycrystalline diamond compact articulation surface and substrate surface topographical features in said polycrystalline diamond compact
US6514289B1 (en) 2000-01-30 2003-02-04 Diamicron, Inc. Diamond articulation surface for use in a prosthetic joint
US6410877B1 (en) 2000-01-30 2002-06-25 Diamicron, Inc. Methods for shaping and finishing prosthetic joint components including polycrystalline diamond compacts
US6402787B1 (en) 2000-01-30 2002-06-11 Bill J. Pope Prosthetic hip joint having at least one sintered polycrystalline diamond compact articulation surface and substrate surface topographical features in said polycrystalline diamond compact
US6709463B1 (en) 2000-01-30 2004-03-23 Diamicron, Inc. Prosthetic joint component having at least one solid polycrystalline diamond component
US6290726B1 (en) 2000-01-30 2001-09-18 Diamicron, Inc. Prosthetic hip joint having sintered polycrystalline diamond compact articulation surfaces
US20100198353A1 (en) * 2000-01-30 2010-08-05 Pope Bill J USE OF Ti and Nb CEMENTED IN TiC IN PROSTHETIC JOINTS
US6610095B1 (en) 2000-01-30 2003-08-26 Diamicron, Inc. Prosthetic joint having substrate surface topographical featurers and at least one diamond articulation surface
US6596225B1 (en) 2000-01-31 2003-07-22 Diamicron, Inc. Methods for manufacturing a diamond prosthetic joint component
US6395799B1 (en) 2000-02-21 2002-05-28 Smith & Nephew, Inc. Electromagnetic and mechanical wave energy treatments of UHMWPE
EP1129731A3 (en) * 2000-02-29 2003-03-26 Howmedica Osteonics Corp. Compositions, processes and methods of improving the wear resistance of prosthetic medical devices
EP1129731A2 (en) 2000-02-29 2001-09-05 Howmedica Osteonics Corp. Compositions, processes and methods of improving the wear resistance of prosthetic medical devices
US7186362B2 (en) 2000-02-29 2007-03-06 Howmedica Osteonics Corp. Methods of improving the wear resistance of prosthetic medical devices
US6566451B2 (en) 2000-02-29 2003-05-20 Howmedica Osteonics Corp. Methods of improving the wear resistance of prosthetic medical devices
US20030220451A1 (en) * 2000-02-29 2003-11-27 Howmedica Osteonics Corp. Methods of improving the wear resistance of prosthetic medical devices
US6436137B2 (en) 2000-02-29 2002-08-20 Howmedica Osteonics Corp. Compositions, processes and methods of improving the wear resistance of prosthetic medical devices
US20050167893A1 (en) * 2000-02-29 2005-08-04 Howmedica Osteonics Corp. Methods of improving the wear resistance of prosthetic medical devices
US6905511B2 (en) 2000-02-29 2005-06-14 Howmedica Oseonics Corp. Methods of improving the wear resistance of prosthetic medical devices
US6414086B1 (en) 2000-02-29 2002-07-02 Howmedica Osteonics Corp. Compositions, processes and methods of improving the wear resistance of prosthetic medical devices
US20040162622A1 (en) * 2000-03-14 2004-08-19 Chondosite, Llc Cartilage repair plug
US6626945B2 (en) 2000-03-14 2003-09-30 Chondrosite, Llc Cartilage repair plug
US6852125B2 (en) 2000-03-14 2005-02-08 Chondrosite, Inc. Cartilage repair plug
US6632246B1 (en) 2000-03-14 2003-10-14 Chondrosite, Llc Cartilage repair plug
US8658710B2 (en) 2000-04-27 2014-02-25 Orthopaedic Hospital Oxidation-resistant and wear-resistant polyethylenes for human joint replacements and methods for making them
US8796347B2 (en) 2000-04-27 2014-08-05 Orthopaedic Hospital Oxidation-resistant and wear-resistant polyethylenes for human joint replacements and methods for making them
US9302028B2 (en) 2000-04-27 2016-04-05 Orthopaedic Hospital Oxidation-resistant and wear-resistant polyethylenes for human joint replacements and methods for making them
US9155817B2 (en) 2000-04-27 2015-10-13 Orthopaedic Hospital Oxidation-resistant and wear-resistant polyethylenes for human joint replacements and methods for making them
US20030212161A1 (en) * 2000-04-27 2003-11-13 Mckellop Harry A Oxidation-resistant and wear-resistant polyethylenes for human joint replacements and methods for making them
WO2001080778A1 (en) * 2000-04-27 2001-11-01 The Orthopaedic Hospital Oxidation-resistant and wear-resistant polyethylenes for human joint replacements and methods for making them
US20070293647A1 (en) * 2000-04-27 2007-12-20 Orthopaedic Hospital Oxidation-resistant and wear-resistant polyethylenes for human joint replacements and methods for making them
EP2047823A1 (en) 2000-04-27 2009-04-15 Orthopaedic Hospital Oxidation-restistant and wear-resistant polyethylenes for human joint replacements and methods for making them
US9242025B2 (en) 2000-04-27 2016-01-26 Orthopaedic Hospital Oxidation-resistant and wear-resistant polyethylenes for human joint replacements and methods for making them
EP2275052A1 (en) 2000-04-27 2011-01-19 Orthopaedic Hospital Oxidation-resistant and wear-resistant polyethylenes for human joint replacements and methods for making them
US9060865B2 (en) 2000-07-31 2015-06-23 The General Hospital Corporation Monopolar constrained acetabular component
US8608806B2 (en) 2000-07-31 2013-12-17 The General Hospital Corporation Monopolar constrained acetabular component
US20070135927A1 (en) * 2000-07-31 2007-06-14 Massachusetts General Hospital acetabular components that decrease risks of dislocation
US7169186B2 (en) 2000-07-31 2007-01-30 Massachusetts General Hospital Monopolar constrained acetabular component
US20030050703A1 (en) * 2000-07-31 2003-03-13 Harris William H. Acetabular components that decrease risks of dislocation
US20030208278A1 (en) * 2000-09-29 2003-11-06 Robert Richard Supercritical fluid treatment of irradiated polyethylene
US20050043815A1 (en) * 2000-09-29 2005-02-24 Richard King Oriented, cross-linked UHMWPE molding for orthopaedic applications
US6818172B2 (en) 2000-09-29 2004-11-16 Depuy Products, Inc. Oriented, cross-linked UHMWPE molding for orthopaedic applications
US9492280B2 (en) 2000-11-28 2016-11-15 Medidea, Llc Multiple-cam, posterior-stabilized knee prosthesis
US10188521B2 (en) 2000-11-28 2019-01-29 Medidea, Llc Multiple-cam, posterior-stabilized knee prosthesis
US7364685B2 (en) 2001-02-05 2008-04-29 Plus Orthopedics Ag Method for producing implant parts from highly cross-linked UHMWPE and implant parts for human medicine
US20040065207A1 (en) * 2001-02-22 2004-04-08 Susumu Oishi Beverages containing catechins
US6726727B2 (en) 2001-02-23 2004-04-27 Smith & Nephew, Inc. Cross-linked ultra-high molecular weight polyethylene for medical implant use
US6547828B2 (en) 2001-02-23 2003-04-15 Smith & Nephew, Inc. Cross-linked ultra-high molecular weight polyethylene for medical implant use
EP2272542A2 (en) 2001-02-23 2011-01-12 Smith and Nephew, Inc. Cross-linked ultra-high molecular weight polyethylene for use as medical implant
US6709464B2 (en) 2001-02-23 2004-03-23 Smith & Nephew, Inc., Research Cross-linked ultra-high molecular weight polyethylene for medical implant use
US7665898B2 (en) 2001-04-22 2010-02-23 Diamicron, Inc. Bearings, races and components thereof having diamond and other superhard surfaces
US20030019106A1 (en) * 2001-04-22 2003-01-30 Diamicron, Inc. Methods for making bearings, races and components thereof having diamond and other superhard surfaces
US20090046967A1 (en) * 2001-04-22 2009-02-19 Pope Bill J Bearings, races and components thereof having diamond and other superhard surfaces
US6652586B2 (en) * 2001-07-18 2003-11-25 Smith & Nephew, Inc. Prosthetic devices employing oxidized zirconium and other abrasion resistant surfaces contacting surfaces of cross-linked polyethylene
US7182784B2 (en) 2001-07-18 2007-02-27 Smith & Nephew, Inc. Prosthetic devices employing oxidized zirconium and other abrasion resistant surfaces contacting surfaces of cross-linked polyethylene
US20040111160A1 (en) * 2001-07-18 2004-06-10 Evans David L. Prosthetic devices employing oxidized zirconium and other abrasion resistant surfaces contacting surfaces of cross-linked polyethylene
US7204947B2 (en) * 2001-09-13 2007-04-17 Orthoplastics Limited Method of crosslinking polyolefins
US20050070625A1 (en) * 2001-09-13 2005-03-31 Perplas Limited Method of crosslinking polyolefins
US20050008886A1 (en) * 2001-10-10 2005-01-13 Hubert Rosing Method for producing polymer semi-products with high and ultra-high molecular weight, resulting semi-products and uses thereof
US20070093909A1 (en) * 2001-12-12 2007-04-26 Richard King Orthopaedic device for implantation in the body of an animal and method for making the same
US20030125513A1 (en) * 2001-12-12 2003-07-03 Richard King Orthopaedic device for implantation in the body of an animal and method for making the same
US7160492B2 (en) 2001-12-12 2007-01-09 Depuy Products, Inc. Orthopaedic device for implantation in the body of an animal and method for making the same
US8076387B2 (en) 2002-01-04 2011-12-13 The General Hospital Corporation High modulus crosslinked polyethylene with reduced residual free radical concentration prepared below the melt
US7166650B2 (en) 2002-01-04 2007-01-23 Massachusetts General Hospital High modulus crosslinked polyethylene with reduced residual free radical concentration prepared below the melt
US6852772B2 (en) 2002-01-04 2005-02-08 Massachusetts Gerneral Hospital High modulus crosslinked polyethylene with reduced residual free radical concentration prepared below the melt
US7304097B2 (en) 2002-01-04 2007-12-04 Massachusetts General Hospital High modulus crosslinked polyethylene with reduced residual free radical concentration prepared below the melt
US20030149125A1 (en) * 2002-01-04 2003-08-07 Muratoglu Orhun K. High modulus crosslinked polyethylene with reduced residual free radical concentration prepared below the melt
US7507774B2 (en) 2002-01-04 2009-03-24 The General Hospital Corporation High modules crosslinked polyethylene with reduced residual free radical concentration prepared below the melt
US20080039545A1 (en) * 2002-01-04 2008-02-14 Massachusetts General Hospital High modulus crosslinked polyethylene with reduced residual free radical concentration prepared below the melt
US20050124718A1 (en) * 2002-01-04 2005-06-09 Massachusetts General Hospital High modulus crosslinked polyethylene with reduced residual free radical concentration prepared below the melt
US7569620B2 (en) 2002-01-04 2009-08-04 Massachusetts General Hospital High modulus crosslinked polyethylene with reduced residual free radical concentration prepared below the melt
US20100262251A1 (en) * 2002-01-04 2010-10-14 The General Hospital Corporation High modulus crosslinked polyethylene with reduced residual free radical concentration prepared below the melt
WO2003059200A1 (en) * 2002-01-04 2003-07-24 Massachusetts General Hospital A high modulus crosslinked polyethylene with reduced residual free radical concentration prepared below the melt
US20090326659A1 (en) * 2002-01-04 2009-12-31 Massachusetts General Hospital High modulus crosslinked polyethylene with reduced residual free radical concentration prepared below the melt
US20080090933A1 (en) * 2002-01-04 2008-04-17 Massachusetts General Hospital High modulus crosslinked polyethylene with reduced residual free radical concentration prepared below the melt
US20070004818A1 (en) * 2002-01-04 2007-01-04 Massachusetts General Hospital High modulus crosslinked polyethylene with reduced residual free radical concentration prepared below the melt
US20070118227A1 (en) * 2002-01-28 2007-05-24 Richard King Composite prosthetic bearing constructed of polyethylene and an ethylene-acrylate copolymer
US7186364B2 (en) 2002-01-28 2007-03-06 Depuy Products, Inc. Composite prosthetic bearing constructed of polyethylene and an ethylene-acrylate copolymer and method for making the same
US20110039014A1 (en) * 2002-01-28 2011-02-17 Richard King Composite prosthetic bearing having a crosslinked articulating surface and method for making the same
US20030144741A1 (en) * 2002-01-28 2003-07-31 Richard King Composite prosthetic bearing having a crosslinked articulating surface and method for making the same
US7819925B2 (en) 2002-01-28 2010-10-26 Depuy Products, Inc. Composite prosthetic bearing having a crosslinked articulating surface and method for making the same
US20080085982A1 (en) * 2002-01-29 2008-04-10 Paul Smith Sintering Ultrahigh Molecular Weight Polyethylene
US7863410B2 (en) 2002-01-29 2011-01-04 Smith & Nephew Orthopaedics Ag Sintering ultrahigh molecular weight polyethylene
US7550555B2 (en) 2002-01-29 2009-06-23 Smith & Nephew Orthopaedics Ag Sintering ultrahigh molecular weight polyethylene
US20100197881A1 (en) * 2002-06-06 2010-08-05 Howmedica Osteonics Corp. Sequentially cross-linked polyethylene
US8680173B2 (en) 2002-06-06 2014-03-25 Howmedica Osteonics Corp. Sequentially cross-linked polyethylene
US20030229155A1 (en) * 2002-06-06 2003-12-11 Howmedica Osteonics Corp. Sequentially cross-linked polyethylene
US8324291B2 (en) 2002-06-06 2012-12-04 Howmedica Osteonics Corp. Sequentially cross-linked polyethylene
US9650476B2 (en) 2002-06-06 2017-05-16 Howmedica Osteonics Corp. Sequentially cross-linked polyethylene
US7517919B2 (en) 2002-06-06 2009-04-14 Howmedica Osteonics Corp. Sequentially cross-linked polyethylene
US9181409B2 (en) 2002-06-06 2015-11-10 Howmedica Osteonics Corp. Sequentially cross-linked polyethylene
US20050043431A1 (en) * 2002-06-06 2005-02-24 Howmedica Osteonics Corp. Sequentially cross-linked polyethylene
US8030370B2 (en) 2002-06-06 2011-10-04 How medica Osteonics Corp. Sequentially cross-linked polyethylene
US7714036B2 (en) 2002-06-06 2010-05-11 Howmedica Osteonics Corp. Sequentially cross-linked polyethylene
US20040002770A1 (en) * 2002-06-28 2004-01-01 King Richard S. Polymer-bioceramic composite for orthopaedic applications and method of manufacture thereof
US8530057B2 (en) 2003-01-16 2013-09-10 The General Hospital Corporation Methods for making oxidation resistant polymeric material
US20090265001A1 (en) * 2003-01-16 2009-10-22 Massachusetts General Hospital Corporation Methods for making oxidation resistant polymeric material
US7498365B2 (en) * 2003-01-16 2009-03-03 The General Hospital Corporation Methods for making oxidation resistant polymeric material
US20050194722A1 (en) * 2003-01-16 2005-09-08 Muratoglu Orhun K. Methods for making oxidation resistant polymeric material
US20050194723A1 (en) * 2003-01-16 2005-09-08 Muratoglu Orhun K. Methods for making oxidation resistant polymeric material
US8038927B2 (en) 2003-01-16 2011-10-18 The General Hosital Corporation Methods for making oxidation resistant polymeric material
US8888859B2 (en) 2003-01-16 2014-11-18 The General Hospital Corporation Methods for making oxidation resistant polymeric material
US20070114702A1 (en) * 2003-01-16 2007-05-24 The General Hospital Corporation Dba Massachusetts General Hospital Methods for making oxidation resistant polymeric material
US7431874B2 (en) 2003-01-16 2008-10-07 Massachusetts General Hospital Methods for making oxidation resistant polymeric material
US20110109017A1 (en) * 2003-01-16 2011-05-12 Massachusetts General Hospital Methods for making oxidation resistant polymeric material
US8728379B2 (en) 2003-01-16 2014-05-20 The General Hospital Corporation Methods for making oxidation resistant polymeric material
US9370878B2 (en) 2003-01-16 2016-06-21 The General Hospital Corp. Methods for making oxidation resistant polymeric material
US20110104003A1 (en) * 2003-01-16 2011-05-05 The General Hospital Corporation Methods for making oxidation resistant polymeric material
US7790095B2 (en) 2003-01-16 2010-09-07 The General Hospital Corporation Methods for making oxidation resistant polymeric material
US10821632B2 (en) 2003-01-16 2020-11-03 The General Hospital Corporation Methods for making oxidation resistant polymeric material
US20040156879A1 (en) * 2003-01-16 2004-08-12 Muratoglu Orhun K. Methods for making oxidation resistant polymeric material
US9943993B2 (en) 2003-01-16 2018-04-17 The General Hospital Corporation Methods for making oxidation resistant polymeric material
US9688004B2 (en) 2003-01-16 2017-06-27 The General Hospital Corporation Methods for making oxidation resistant polymeric material
US8968628B2 (en) 2003-01-16 2015-03-03 The General Hospital Corp. Methods for making oxidation resistant polymeric material
US20080067724A1 (en) * 2003-01-16 2008-03-20 Massachusetts General Hospital Methods for making oxidation resistant polymeric material
US7906064B2 (en) * 2003-01-16 2011-03-15 The General Hospital Corporation Methods for making oxidation resistant polymeric material
US20040210316A1 (en) * 2003-04-15 2004-10-21 Richard King Implantable orthopaedic device and method for making the same
US7938861B2 (en) 2003-04-15 2011-05-10 Depuy Products, Inc. Implantable orthopaedic device and method for making the same
US20060243624A1 (en) * 2003-06-10 2006-11-02 Meadwestvaco Corporation Resin packaging
US20080178998A1 (en) * 2003-06-30 2008-07-31 Smith Todd S Crosslinked polymeric composite for orthopaedic implants
US20040262809A1 (en) * 2003-06-30 2004-12-30 Smith Todd S. Crosslinked polymeric composite for orthopaedic implants
US20040266903A1 (en) * 2003-06-30 2004-12-30 Depuy Products, Inc. Free radical quench process for irradiated ultrahigh molecular weight polyethylene
US7214764B2 (en) 2003-06-30 2007-05-08 Depuy Products, Inc. Free radical quench process for irradiated ultrahigh molecular weight polyethylene
US20040265165A1 (en) * 2003-06-30 2004-12-30 Depuy Products, Inc. Free radical quench process for irradiated ultrahigh molecular weight polyethylene
US20050133277A1 (en) * 2003-08-28 2005-06-23 Diamicron, Inc. Superhard mill cutters and related methods
US20080033573A1 (en) * 2003-09-19 2008-02-07 Depuy Products, Inc. Medical implant or medical implant part comprising porous uhmwpe and process for producing the same
US20100283184A1 (en) * 2003-09-19 2010-11-11 Depuy Products, Inc. Process for producing medical implant or medical implant part comprising porous uhmwpe
US7923512B2 (en) 2003-09-19 2011-04-12 Depuy Products, Inc. Process for producing medical implant or medical implant part comprising porous UHMWPE
US7781526B2 (en) 2003-09-19 2010-08-24 Depuy Products, Inc. Medical implant or medical implant part comprising porous UHMWPE and process for producing the same
US7785508B2 (en) 2003-09-30 2010-08-31 Depuy Products, Inc. Method for producing medical implant or medical implant part
US20080044676A1 (en) * 2003-09-30 2008-02-21 Depuy Products, Inc. Method for producing medical implant or medical implant part
EP1520877A1 (en) 2003-09-30 2005-04-06 Depuy Products, Inc. Medical implant or medical implant part with ultrahigh molecular weight polyethylene and at least one hydrophilic polymer
US8865043B2 (en) 2004-05-11 2014-10-21 The General Hospital Corporation Methods for making oxidation resistant polymeric material
US7833452B2 (en) 2004-05-11 2010-11-16 The General Hospital Corporation Method for making oxidation resistant polymeric material
US9561306B2 (en) 2004-05-11 2017-02-07 The General Hospital Corporation Methods for making oxidation resistant polymeric material
US20080090934A1 (en) * 2004-05-11 2008-04-17 The General Hospital Corporation Dba Massachusetts General Hospital Methods for making oxidation resistant polymeric material
US8318065B2 (en) 2004-05-11 2012-11-27 The General Hospital Corporation Methods for making oxidation resistant polymeric material
US20080119582A1 (en) * 2004-05-11 2008-05-22 The General Hospital Corporation Dba Massachusetts General Hospital Method For Making Oxidation Resistant Polymeric Material
US7384430B2 (en) 2004-06-30 2008-06-10 Depuy Products, Inc. Low crystalline polymeric material for orthopaedic implants and an associated method
US20060004168A1 (en) * 2004-06-30 2006-01-05 Keith Greer Low crystalline polymeric material for orthopaedic implants and an associated method
US7344672B2 (en) 2004-10-07 2008-03-18 Biomet Manufacturing Corp. Solid state deformation processing of crosslinked high molecular weight polymeric materials
US8398913B2 (en) 2004-10-07 2013-03-19 Biomet Manufacturing Corp. Solid state deformation processing of crosslinked high molecular weight polymeric materials
US20100314800A1 (en) * 2004-10-07 2010-12-16 Biomet Manufacturing Corporation Solid state deformation processing of crosslinked high molecular weight polymeric materials
US7927536B2 (en) 2004-10-07 2011-04-19 Biomet Manufacturing Corp. Solid state deformation processing of crosslinked high molecular weight polymeric materials
US8262976B2 (en) 2004-10-07 2012-09-11 Biomet Manufacturing Corp. Solid state deformation processing of crosslinked high molecular weight polymeric materials
US7547405B2 (en) 2004-10-07 2009-06-16 Biomet Manufacturing Corp. Solid state deformation processing of crosslinked high molecular weight polymeric materials
US7780896B2 (en) 2004-10-07 2010-08-24 Biomet Manufacturing Corp. Crosslinked polymeric material with enhanced strength and process for manufacturing
US9017590B2 (en) 2004-10-07 2015-04-28 Biomet Manufacturing, Llc Solid state deformation processing of crosslinked high molecular weight polymeric materials
US8137608B2 (en) 2004-10-07 2012-03-20 Biomet Manufacturing Corp. Crosslinked polymeric material with enhanced strength and process for manufacturing
US20060079596A1 (en) * 2004-10-07 2006-04-13 Schroeder David W Crosslinked polymeric material with enhanced strength and process for manufacturing
US20100298945A1 (en) * 2004-10-07 2010-11-25 Biomet Manufacturing Corp. Crosslinked polymeric material with enhanced strength and process for manufacturing
US20060079595A1 (en) * 2004-10-07 2006-04-13 Schroeder David W Solid state deformation processing of crosslinked high molecular weight polymeric materials
US20090082546A1 (en) * 2004-10-07 2009-03-26 Biomet Manufacturing Corp. Crosslinked polymeric material with enhanced strength and process for manufacturing
US7462318B2 (en) 2004-10-07 2008-12-09 Biomet Manufacturing Corp. Crosslinked polymeric material with enhanced strength and process for manufacturing
US7993401B2 (en) 2004-10-07 2011-08-09 Biomet Manufacturing Corp. Solid state deformation processing of crosslinked high molecular weight polymeric materials
US20060142868A1 (en) * 2004-12-21 2006-06-29 Zimmer Technology, Inc. Selective crosslinking of orthopaedic implants
EP2113530A1 (en) 2004-12-23 2009-11-04 DePuy Products, Inc. Polymer composition comprising cross-linked polyethylene
US7335697B2 (en) 2004-12-23 2008-02-26 Depuy Products, Inc. Polymer composition comprising cross-linked polyethylene and methods for making the same
US20060142449A1 (en) * 2004-12-23 2006-06-29 Depuy Products, Inc. Polymer composition comprising cross-linked polyethylene and methods for making the same
US7883653B2 (en) 2004-12-30 2011-02-08 Depuy Products, Inc. Method of making an implantable orthopaedic bearing
US7879275B2 (en) 2004-12-30 2011-02-01 Depuy Products, Inc. Orthopaedic bearing and method for making the same
US20060149387A1 (en) * 2004-12-30 2006-07-06 Smith Todd S Orthopaedic bearing and method for making the same
US20060149388A1 (en) * 2004-12-30 2006-07-06 Smith Todd S Orthopaedic bearing and method for making the same
US7896921B2 (en) 2004-12-30 2011-03-01 Depuy Products, Inc. Orthopaedic bearing and method for making the same
WO2006107400A2 (en) * 2005-03-31 2006-10-12 Zimmer, Inc. Liquid bath annealing of polymers for orthopaedic implants
US7435372B2 (en) 2005-03-31 2008-10-14 Zimmer, Inc. Liquid bath annealing of polymers for orthopaedic implants
WO2006107400A3 (en) * 2005-03-31 2007-03-29 Zimmer Tech Inc Liquid bath annealing of polymers for orthopaedic implants
US20060223905A1 (en) * 2005-03-31 2006-10-05 Zimmer Technology, Inc. Liquid bath annealing of polymers for orthopaedic implants
US8449991B2 (en) 2005-04-07 2013-05-28 Dimicron, Inc. Use of SN and pore size control to improve biocompatibility in polycrystalline diamond compacts
US20090263643A1 (en) * 2005-04-07 2009-10-22 Gardinier Clayton F Use of sn and pore size control to improve biocompatibility in polycrystalline diamond compacts
US9463092B2 (en) 2005-04-07 2016-10-11 Dimicron, Inc. Use of Sn and pore size control to improve biocompatibility in polycrystalline diamond compacts
US20090220580A1 (en) * 2005-04-20 2009-09-03 Senju Pharmaceutical Co., Ltd. Percutaneous Absorption Formulation
US20080197541A1 (en) * 2005-06-14 2008-08-21 Omni Life Science, Inc Crosslinked Polyethylene Article
US7803310B2 (en) 2005-06-14 2010-09-28 Omni Life Science, Inc. Crosslinked polyethylene article
US20090212343A1 (en) * 2005-06-15 2009-08-27 Actel Corporation Non-volatile two-transistor programmable logic cell and array layout
US8673202B2 (en) 2005-08-18 2014-03-18 Zimmer, Gmbh Ultra high molecular weight polyethylene articles and methods of forming ultra high molecular weight polyethylene articles
US11001680B2 (en) 2005-08-18 2021-05-11 Zimmer Gmbh Ultra high molecular weight polyethylene articles and methods of forming ultra high molecular weight polyethylene articles
US20110135917A1 (en) * 2005-08-18 2011-06-09 Zimmer Gmbh Ultra High Molecular Weight Polyethylene Articles And Methods Of Forming Ultra High Molecular Weight Polyethylene Articles
US11015030B2 (en) 2005-08-18 2021-05-25 Zimmer Gmbh Ultra high molecular weight polyethylene articles and methods of forming ultra high molecular weight polyethylene articles
US8461225B2 (en) 2005-08-22 2013-06-11 The General Hospital Corporation Oxidation resistant homogenized polymeric material
WO2007024689A3 (en) * 2005-08-22 2007-11-08 Gen Hospital Corp Dba Massachu Oxidation resistant homogenized polymeric material
US8889757B2 (en) 2005-08-22 2014-11-18 The General Hospital Corporation Oxidation resistant homogenized polymeric material
US20080214692A1 (en) * 2005-08-22 2008-09-04 The General Hospital Corporation Dba Massachusetts General Hospital Oxidation resistant homogenized polymeric material
US8343230B2 (en) 2005-09-22 2013-01-01 Depuy Products, Inc. Orthopaedic bearing material
US20070067044A1 (en) * 2005-09-22 2007-03-22 Depuy Products, Inc. Orthopaedic bearing material
US20070077268A1 (en) * 2005-09-30 2007-04-05 Depuy Products, Inc. Hydrophobic carrier modified implants for beneficial agent delivery
US20070232761A1 (en) * 2006-03-31 2007-10-04 Depuy Products, Inc. Bearing material of medical implant having reduced wear rate and method for reducing wear rate
US7812098B2 (en) 2006-03-31 2010-10-12 Depuy Products, Inc. Bearing material of medical implant having reduced wear rate and method for reducing wear rate
US20070232716A1 (en) * 2006-04-04 2007-10-04 Fina Technology, Inc. Cross-linking resins
US7683133B2 (en) 2006-08-25 2010-03-23 Depuy Products, Inc. Bearing material of medical implant and methods for making it
US20100137522A1 (en) * 2006-08-25 2010-06-03 Depuy Products, Inc. Bearing material of medical implant and methods for making it
US8871131B2 (en) 2006-10-30 2014-10-28 Smith And Nephew Orthopaedics Ag Processes comprising crosslinking polyethylene or using crosslinked polyethylene
US20100069576A1 (en) * 2006-10-30 2010-03-18 Smith & Nephew Orthopaedics Ag Processes comprising crosslinking polyethylene or using crosslinked polyethylene
US9968709B2 (en) 2007-01-25 2018-05-15 The General Hospital Corporation Methods for making oxidation-resistant cross-linked polymeric materials
US20120292816A1 (en) * 2007-01-25 2012-11-22 Cambridge Polymer Group, Inc. Methods for making oxidation-resistant cross-linked polymeric materials
US9433705B2 (en) 2007-01-25 2016-09-06 The General Hospital Corp. Methods for making oxidation-resistant cross-linked polymeric materials
US8569395B2 (en) * 2007-01-25 2013-10-29 The General Hospital Corporation Methods for making oxidation-resistant cross-linked polymeric materials
US20100190882A1 (en) * 2007-01-25 2010-07-29 The General Hosital Corporation Methods for making oxidation-resistant cross-linked polymeric materials
US8293811B2 (en) * 2007-01-25 2012-10-23 The General Hospital Corporation Methods for making oxidation-resistant cross-linked polymeric materials
US20100190920A1 (en) * 2007-02-14 2010-07-29 Anuj Bellare Crosslinked polymers and methods of making the same
US20100144930A1 (en) * 2007-03-20 2010-06-10 Smith & Nephew Orthopaedics Ag Oxidation resistant highly-crosslinked uhmwpe
US9926432B2 (en) 2007-04-10 2018-03-27 Zimmer, Inc. Antioxidant stabilized crosslinked ultra-high molecular weight polyethylene for medical device applications
US9277949B2 (en) 2007-04-10 2016-03-08 Zimmer, Inc. Antioxidant stabilized crosslinked ultra high molecular weight polyethylene for medical device applications
US9265545B2 (en) 2007-04-10 2016-02-23 Zimmer, Inc. Antioxidant stabilized crosslinked ultra-high molecular weight polyethylene for medical device applications
US20110028600A1 (en) * 2007-04-10 2011-02-03 Zimmer, Inc. Antioxidant stabilized crosslinked ultra-high molecular weight polyethylene for medical device applications
US8664290B2 (en) 2007-04-10 2014-03-04 Zimmer, Inc. Antioxidant stabilized crosslinked ultra-high molecular weight polyethylene for medical device applications
US9822224B2 (en) 2007-04-10 2017-11-21 Zimmer, Inc. Antioxidant stabilized crosslinked ultra high molecular weight polyethylene for medical device applications
US8669299B2 (en) 2007-04-10 2014-03-11 Zimmer, Inc. Antioxidant stabilized crosslinked ultra-high molecular weight polyethylene for medical device applications
US10556998B2 (en) 2007-04-10 2020-02-11 Zimmer, Inc. Antioxidant stabilized crosslinked ultra high molecular weight polyethylene for medical device applications
US9421104B2 (en) 2007-07-27 2016-08-23 Biomet Manufacturing, Llc Antioxidant doping of crosslinked polymers to form non-eluting bearing components
US8641959B2 (en) 2007-07-27 2014-02-04 Biomet Manufacturing, Llc Antioxidant doping of crosslinked polymers to form non-eluting bearing components
US20090030524A1 (en) * 2007-07-27 2009-01-29 Biomet Manufacturing Corp. Antioxidant doping of crosslinked polymers to form non-eluting bearing components
US20110112646A1 (en) * 2007-09-04 2011-05-12 Smith & Nephew, Inc. Ultra high molecular weight polyethylene for bearing surfaces
US8546460B2 (en) 2007-09-04 2013-10-01 Smith & Nephew, Inc. Ultra high molecular weight polyethylene for bearing surfaces
US9398956B2 (en) 2007-09-25 2016-07-26 Depuy (Ireland) Fixed-bearing knee prosthesis having interchangeable components
US20100063594A1 (en) * 2007-09-28 2010-03-11 Hazebrouck Stephen A Fixed-bearing knee prosthesis having interchangeable components
US9204967B2 (en) 2007-09-28 2015-12-08 Depuy (Ireland) Fixed-bearing knee prosthesis having interchangeable components
US8128703B2 (en) 2007-09-28 2012-03-06 Depuy Products, Inc. Fixed-bearing knee prosthesis having interchangeable components
US20110036748A1 (en) * 2007-10-12 2011-02-17 Peak Plastic & Metal Products Wafer Container With Staggered Wall Structure
US9238719B2 (en) * 2007-11-06 2016-01-19 Dsm Ip Assets B.V. Process for producing high molecular weight polyethylene
US20100331995A1 (en) * 2007-11-06 2010-12-30 Harold Jan Smelt Process for producing high molecular weight polyethylene
US9290629B2 (en) * 2007-11-06 2016-03-22 Dsm Ip Assets B.V. Process for producing high molecular weight polyethylene
US20160184476A1 (en) * 2007-11-06 2016-06-30 Dsm Ip Assets B.V. Process for producing high molecular weight polyethylene
US9555160B2 (en) * 2007-11-06 2017-01-31 Dsm Ip Assets B.V. Process for producing high molecular weight polyethylene
US20150203641A1 (en) * 2007-11-06 2015-07-23 Dsm Ip Assets B.V. Process for producing high molecular weight polyethylene
US10118998B2 (en) * 2007-11-06 2018-11-06 Dsm Ip Assets B.V. Process for producing high molecular weight polyethylene
US9718241B2 (en) 2008-01-30 2017-08-01 Zimmer, Inc. Method of manufacturing an acetabular component
US8652212B2 (en) 2008-01-30 2014-02-18 Zimmer, Inc. Orthopedic component of low stiffness
US20090192610A1 (en) * 2008-01-30 2009-07-30 Zimmer, Inc. Orthopedic component of low stiffness
US8586667B2 (en) 2008-05-13 2013-11-19 Smith & Nephew Orthopaedics Ag Oxidation resistant highly-crosslinked UHMWPE
US20110116968A1 (en) * 2008-05-13 2011-05-19 Smith & Nephew Orthopaedics Ag Oxidation resistant highly-crosslinked uhmwpe
US20090288366A1 (en) * 2008-05-23 2009-11-26 Phillip Andrew Schorr Vacuum packaged products and methods for making same
US8323562B2 (en) 2008-05-23 2012-12-04 Kimberly-Clark Worldwide, Inc. Vacuum packaged products and methods for making same
US10265180B2 (en) 2008-06-30 2019-04-23 Depuy Ireland Unlimited Company Orthopaedic knee prosthesis having controlled condylar curvature
US9539099B2 (en) 2008-06-30 2017-01-10 Depuy Ireland Unlimited Company Orthopaedic knee prosthesis having controlled condylar curvature
US9204968B2 (en) 2008-06-30 2015-12-08 Depuy (Ireland) Posterior stabilized orthopaedic prosthesis
US8834575B2 (en) 2008-06-30 2014-09-16 Depuy (Ireland) Posterior stabilized orthopaedic knee prosthesis having controlled condylar curvature
US9220601B2 (en) 2008-06-30 2015-12-29 Depuy (Ireland) Orthopaedic femoral component having controlled condylar curvature
US8828086B2 (en) 2008-06-30 2014-09-09 Depuy (Ireland) Orthopaedic femoral component having controlled condylar curvature
US8795380B2 (en) 2008-06-30 2014-08-05 Depuy (Ireland) Orthopaedic knee prosthesis having controlled condylar curvature
US8784496B2 (en) 2008-06-30 2014-07-22 Depuy (Ireland) Orthopaedic knee prosthesis having controlled condylar curvature
US8734522B2 (en) 2008-06-30 2014-05-27 Depuy (Ireland) Posterior stabilized orthopaedic prosthesis
US8206451B2 (en) 2008-06-30 2012-06-26 Depuy Products, Inc. Posterior stabilized orthopaedic prosthesis
US9168145B2 (en) 2008-06-30 2015-10-27 Depuy (Ireland) Posterior stabilized orthopaedic knee prosthesis having controlled condylar curvature
US9326864B2 (en) 2008-06-30 2016-05-03 Depuy (Ireland) Orthopaedic knee prosthesis having controlled condylar curvature
US11730602B2 (en) 2008-06-30 2023-08-22 Depuy Ireland Unlimited Company Orthopaedic knee prosthesis having controlled condylar curvature
US10729551B2 (en) 2008-06-30 2020-08-04 Depuy Ireland Unlimited Company Orthopaedic knee prosthesis having controlled condylar curvature
US20090326667A1 (en) * 2008-06-30 2009-12-31 Williams John L Orthopaedic femoral component having controlled condylar curvature
US11337823B2 (en) 2008-06-30 2022-05-24 Depuy Ireland Unlimited Company Orthopaedic femoral component having controlled condylar curvature
US8192498B2 (en) 2008-06-30 2012-06-05 Depuy Products, Inc. Posterior cructiate-retaining orthopaedic knee prosthesis having controlled condylar curvature
US8236061B2 (en) 2008-06-30 2012-08-07 Depuy Products, Inc. Orthopaedic knee prosthesis having controlled condylar curvature
US9452053B2 (en) 2008-06-30 2016-09-27 Depuy (Ireland) Orthopaedic knee prosthesis having controlled condylar curvature
US20100036500A1 (en) * 2008-06-30 2010-02-11 Heldreth Mark A Orthopaedic knee prosthesis having controlled condylar curvature
US20090326664A1 (en) * 2008-06-30 2009-12-31 Wagner Christel M Posterior cructiate-retaining orthopaedic knee prosthesis having controlled condylar curvature
US10543098B2 (en) 2008-06-30 2020-01-28 Depuy Ireland Unlimited Company Orthopaedic femoral component having controlled condylar curvature
US9937049B2 (en) 2008-06-30 2018-04-10 Depuy Ireland Unlimited Company Orthopaedic knee prosthesis having controlled condylar curvature
US9931216B2 (en) 2008-06-30 2018-04-03 Depuy Ireland Unlimited Company Orthopaedic femoral component having controlled condylar curvature
US10849760B2 (en) 2008-06-30 2020-12-01 Depuy Ireland Unlimited Company Orthopaedic knee prosthesis having controlled condylar curvature
US20090326665A1 (en) * 2008-06-30 2009-12-31 Wyss Joseph G Posterior stabilized orthopaedic knee prosthesis having controlled condylar curvature
US8187335B2 (en) 2008-06-30 2012-05-29 Depuy Products, Inc. Posterior stabilized orthopaedic knee prosthesis having controlled condylar curvature
US11369478B2 (en) 2008-06-30 2022-06-28 Depuy Ireland Unlimited Company Orthopaedic knee prosthesis having controlled condylar curvature
US10179051B2 (en) 2008-06-30 2019-01-15 Depuy Ireland Unlimited Company Orthopaedic knee prosthesis having controlled condylar curvature
US9119723B2 (en) 2008-06-30 2015-09-01 Depuy (Ireland) Posterior stabilized orthopaedic prosthesis assembly
US20100022678A1 (en) * 2008-07-24 2010-01-28 Zimmer, Inc. Reduction of free radicals in crosslinked polyethylene by infrared heating
US8439975B2 (en) 2008-08-05 2013-05-14 Howmedica Osteonics Corp. Polyethylene cross-linked with an anthocyanin
US8133436B2 (en) 2008-08-05 2012-03-13 Howmedica Osteonics Corp. Polyethylene cross-linked with an anthocyanin
US20100036491A1 (en) * 2008-08-05 2010-02-11 Howmedica Osteonics Corp. Polyethylene cross-linked with an anthocyanin
US20110224325A1 (en) * 2008-08-05 2011-09-15 Howmedica Osteonics Corp. Polyethylene cross-linked with an anthocyanin
US8303657B2 (en) 2008-08-05 2012-11-06 Howmedica Osteonics Corp. Polyethylene cross-linked with an anthocyanin
US8241564B1 (en) 2008-08-05 2012-08-14 Howmedica Osteonics Corp. Polyethylene cross-linked with an anthocyanin
DE102008053793A1 (en) 2008-10-21 2010-04-22 Aesculap Ag Synthetic polymer material, useful for producing medical articles e.g. catheters and trocar, comprises amino acids and/or peptides having anti-oxidative effect
US9820539B2 (en) 2009-06-26 2017-11-21 Dimicron, Inc. Thick sintered polycrystalline diamond and sintered jewelry
US20110146348A1 (en) * 2009-06-26 2011-06-23 Harding David P Thick sintered polycrystalline diamond and sintered jewelry
US8663359B2 (en) 2009-06-26 2014-03-04 Dimicron, Inc. Thick sintered polycrystalline diamond and sintered jewelry
US9011547B2 (en) 2010-01-21 2015-04-21 Depuy (Ireland) Knee prosthesis system
US9382023B2 (en) 2010-01-22 2016-07-05 Allegiance Corporation Methods for packaging and sterilizing elastomeric articles, and packaged elastomeric articles produced thereby
US10472110B2 (en) 2010-01-22 2019-11-12 Allegiance Corporation Methods for packaging and sterilizing elastomeric articles and packaged elastomeric articles produced thereby
US10421569B2 (en) 2010-01-22 2019-09-24 Allegiance Corporation Methods for packaging and sterilizing elastomeric articles and packaged elastomeric articles produced thereby
EP2384774A2 (en) 2010-05-07 2011-11-09 Howmedica Osteonics Corp. Surface crosslinked polyethylene
US20150137428A1 (en) * 2011-05-09 2015-05-21 Abbott Cardiovascular Systems Inc. Methods of stabilizing molecular weight of polymer stents after sterilization
US20150128527A1 (en) * 2011-05-09 2015-05-14 Abbott Cardiovascular Systems Inc. Methods of stabilizing molecular weight of polymer stents after sterilization
US20140262858A1 (en) * 2011-10-21 2014-09-18 Ranbaxy Laboratories Limited Packaging for alitretinoin
US9586370B2 (en) 2013-08-15 2017-03-07 Biomet Manufacturing, Llc Method for making ultra high molecular weight polyethylene
US9708467B2 (en) 2013-10-01 2017-07-18 Zimmer, Inc. Polymer compositions comprising one or more protected antioxidants
US10184031B2 (en) 2014-03-12 2019-01-22 Zimmer, Inc. Melt-stabilized ultra high molecular weight polyethylene and method of making the same
EP2921186A1 (en) 2014-03-21 2015-09-23 Howmedica Osteonics Corp. Annealing method for cross-linked polyethylene
US10265891B2 (en) 2014-12-03 2019-04-23 Zimmer, Inc. Antioxidant-infused ultra high molecular weight polyethylene
US11952439B2 (en) 2020-06-25 2024-04-09 b-ONE Medical (Suzhou) Co., Ltd. Surface gradient cross-linking method of ultra-high molecular weight polyethylene and the application thereof

Also Published As

Publication number Publication date
DE9490446U1 (en) 1997-02-20
US6818020B2 (en) 2004-11-16
US5728748A (en) 1998-03-17
US20050059750A1 (en) 2005-03-17
DE69425838D1 (en) 2000-10-12
WO1994027651A1 (en) 1994-12-08
EP1005872B1 (en) 2005-08-17
EP0701453A1 (en) 1996-03-20
US5650485A (en) 1997-07-22
US5543471A (en) 1996-08-06
DE69425838T2 (en) 2001-04-12
ES2122260T3 (en) 1998-12-16
US20030207957A1 (en) 2003-11-06
AU6436494A (en) 1994-12-20
JPH08509148A (en) 1996-10-01
DE69413395T2 (en) 1999-02-04
EP0701453B1 (en) 1998-09-16
US20020107299A1 (en) 2002-08-08
ATE196095T1 (en) 2000-09-15
US6174934B1 (en) 2001-01-16
AU684500B2 (en) 1997-12-18
DE69434462D1 (en) 2005-09-22
US5449745A (en) 1995-09-12
EP0847765B1 (en) 2000-09-06
US6372814B1 (en) 2002-04-16
JP2836965B2 (en) 1998-12-14
ATE302032T1 (en) 2005-09-15
CA2162927C (en) 2000-07-04
US6664308B2 (en) 2003-12-16
ATE171078T1 (en) 1998-10-15
DE69434462T2 (en) 2006-06-08
EP1005872A1 (en) 2000-06-07
EP0847765A1 (en) 1998-06-17
DE69413395D1 (en) 1998-10-22
EP1598086A2 (en) 2005-11-23

Similar Documents

Publication Publication Date Title
US5414049A (en) Non-oxidizing polymeric medical implant
US7714036B2 (en) Sequentially cross-linked polyethylene
EP1919983B1 (en) Oxidation resistant homogenized polymeric material
US8241564B1 (en) Polyethylene cross-linked with an anthocyanin
EP2921186B1 (en) Annealing method for cross-linked polyethylene

Legal Events

Date Code Title Description
AS Assignment

Owner name: HOWMEDICA, INC., NEW YORK

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:SUN, DEH-CHUAN;STARK, CASPER F.;REEL/FRAME:006567/0885

Effective date: 19930601

STPP Information on status: patent application and granting procedure in general

Free format text: APPLICATION UNDERGOING PREEXAM PROCESSING

FEPP Fee payment procedure

Free format text: PAYOR NUMBER ASSIGNED (ORIGINAL EVENT CODE: ASPN); ENTITY STATUS OF PATENT OWNER: LARGE ENTITY

REMI Maintenance fee reminder mailed
FEPP Fee payment procedure

Free format text: PAYER NUMBER DE-ASSIGNED (ORIGINAL EVENT CODE: RMPN); ENTITY STATUS OF PATENT OWNER: LARGE ENTITY

Free format text: PAYOR NUMBER ASSIGNED (ORIGINAL EVENT CODE: ASPN); ENTITY STATUS OF PATENT OWNER: LARGE ENTITY

FPAY Fee payment

Year of fee payment: 4

SULP Surcharge for late payment
AS Assignment

Owner name: STRYKER TECHNOLOGIES CORPORATION, MICHIGAN

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:HOWMEDICA INC.;REEL/FRAME:009781/0191

Effective date: 19981202

AS Assignment

Owner name: BANK OF AMERICA NATIONAL TRUST AND SAVINGS ASSOCIA

Free format text: SECURITY INTEREST;ASSIGNORS:STRYKER CORPORATION;STRYKER FAR EAST, INC.;STRYKER INTERNATIONAL INC.;AND OTHERS;REEL/FRAME:009817/0001

Effective date: 19981204

Owner name: BANK OF AMERICA NATIONAL TRUST AND SAVINGS ASSOCIA

Free format text: SECURITY AGREEMENT;ASSIGNORS:STRYKER CORPORATION;STRYKER FAR EAST, INC.;REEL/FRAME:014137/0212

Effective date: 19981204

AS Assignment

Owner name: STRYKER CORPORATION, MICHIGAN

Free format text: RELEASE OF SECURITY INTEREST;ASSIGNOR:BANK OF AMERICA, N.A. (F/K/A BANK OF AMERICA NATIONAL TRUST AND SAVINGS ASSOCIATION);REEL/FRAME:012539/0557

Effective date: 20020124

Owner name: STRYKER FAR EAST, INC., MICHIGAN

Free format text: RELEASE OF SECURITY INTEREST;ASSIGNOR:BANK OF AMERICA, N.A. (F/K/A BANK OF AMERICA NATIONAL TRUST AND SAVINGS ASSOCIATION);REEL/FRAME:012539/0557

Effective date: 20020124

Owner name: STRYKER INTERNATIONAL, INC., MICHIGAN

Free format text: RELEASE OF SECURITY INTEREST;ASSIGNOR:BANK OF AMERICA, N.A. (F/K/A BANK OF AMERICA NATIONAL TRUST AND SAVINGS ASSOCIATION);REEL/FRAME:012539/0557

Effective date: 20020124

Owner name: HOWMEDICA OSTEONICS CORPORATION, MICHIGAN

Free format text: RELEASE OF SECURITY INTEREST;ASSIGNOR:BANK OF AMERICA, N.A. (F/K/A BANK OF AMERICA NATIONAL TRUST AND SAVINGS ASSOCIATION);REEL/FRAME:012539/0557

Effective date: 20020124

Owner name: PHYSIOTHERAPY ASSOCIATES, INC., MICHIGAN

Free format text: RELEASE OF SECURITY INTEREST;ASSIGNOR:BANK OF AMERICA, N.A. (F/K/A BANK OF AMERICA NATIONAL TRUST AND SAVINGS ASSOCIATION);REEL/FRAME:012539/0557

Effective date: 20020124

Owner name: STRYKER PUERTO RICO INC., MICHIGAN

Free format text: RELEASE OF SECURITY INTEREST;ASSIGNOR:BANK OF AMERICA, N.A. (F/K/A BANK OF AMERICA NATIONAL TRUST AND SAVINGS ASSOCIATION);REEL/FRAME:012539/0557

Effective date: 20020124

Owner name: STRYKER SALES CORPORATION, MICHIGAN

Free format text: RELEASE OF SECURITY INTEREST;ASSIGNOR:BANK OF AMERICA, N.A. (F/K/A BANK OF AMERICA NATIONAL TRUST AND SAVINGS ASSOCIATION);REEL/FRAME:012539/0557

Effective date: 20020124

Owner name: STRYKER TECHNOLOGIES CORPORATION, MICHIGAN

Free format text: RELEASE OF SECURITY INTEREST;ASSIGNOR:BANK OF AMERICA, N.A. (F/K/A BANK OF AMERICA NATIONAL TRUST AND SAVINGS ASSOCIATION);REEL/FRAME:012539/0557

Effective date: 20020124

Owner name: STRYKER FOREIGN HOLDCO, INC., MICHIGAN

Free format text: RELEASE OF SECURITY INTEREST;ASSIGNOR:BANK OF AMERICA, N.A. (F/K/A BANK OF AMERICA NATIONAL TRUST AND SAVINGS ASSOCIATION);REEL/FRAME:012539/0557

Effective date: 20020124

Owner name: SMD CORPORATION, MICHIGAN

Free format text: RELEASE OF SECURITY INTEREST;ASSIGNOR:BANK OF AMERICA, N.A. (F/K/A BANK OF AMERICA NATIONAL TRUST AND SAVINGS ASSOCIATION);REEL/FRAME:012539/0557

Effective date: 20020124

Owner name: HOWMEDICAL LEIBINGER, INC., MICHIGAN

Free format text: RELEASE OF SECURITY INTEREST;ASSIGNOR:BANK OF AMERICA, N.A. (F/K/A BANK OF AMERICA NATIONAL TRUST AND SAVINGS ASSOCIATION);REEL/FRAME:012539/0557

Effective date: 20020124

FPAY Fee payment

Year of fee payment: 8

AS Assignment

Owner name: HOWMEDICA OSTEONICS CORP., NEW JERSEY

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:STRYKER TECHNOLOGIES CORPORATION;REEL/FRAME:015044/0484

Effective date: 20031217

FPAY Fee payment

Year of fee payment: 12